UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

FORM 10-K

[X] ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the fiscal year ended April 30, 2016

[ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from ___________ to ___________

Commission file number 333-174607

JOYMAIN INTERNATIONAL DEVELOPMENT GROUP INC.
(Exact name of registrant as specified in its charter)

Nevada	5070	68-0681552
State or jurisdiction of	Primary Standard Industrial	IRS Employer
incorporation	Classification Code Number	Identification Number
or organization

2719 Hollywood Blvd, Hollywood, FL33020
Tel: 1-786-232-3083
(Address, including zip code, and telephone number,
including area code, of registrant’s principal executive offices)

Securities registered pursuant to Section 12(b) of the Act: None

Securities registered pursuant to Section 12(g) of the Act: None

Indicate by check mark whether the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act.
Yes [ ] No [X]

Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.
Yes [ ] No [X]

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for shorter period that the registrant as required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.
Yes [X] No [ ]

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Website, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-K (§229.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).
Yes [ ] No [ ]

Indicate by check mark if disclosure of delinquent filers pursuant to Item 405 of Regulation S-K is not contained herein, and will not be contained, to the best of registrant's knowledge, in definitive proxy or information statements incorporated by reference in Part III of this Form 10-K or any amendment to this Form 10-K. [ ]

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, or a non-accelerated filer. See definition of "accelerated filer and large accelerated filer" in Rule 12b-2 of the Exchange Act. (Check one):

Large accelerated filer [ ]	Accelerated filer [ X ]
Non-accelerated filer [ ]	Smaller reporting company [ ]

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act)
Yes [ ] No [X]

The aggregate market value of Common Stock held by non-affiliates of the Registrant on October 26, 2015, the last business day of the registrant’s most recently completed second fiscal quarter, was $576,346,385 based on a $1.30 which is the average of the bid and asked price of the Common Stock.

As of August 18, 2016, the registrant had 1,120,343,373 shares of common stock issued and outstanding.

DOCUMENTS INCORPORATED BY REFERENCE

None.

TABLE OF CONTENTS

ITEM 1.	BUSINESS	5
ITEM 1A.	RISK FACTORS	11
ITEM 1B.	UNRESOLVED STAFF COMMENTS	15
ITEM 2.	PROPERTIES	15
ITEM 3.	LEGAL PROCEEDINGS	15
ITEM 4.	MINE SAFETY DISCLOSURES	15
ITEM 5.	MARKET FOR REGISTRANT’S COMMON EQUITY, RELATED STOCKHOLDER MATTERS AND ISSUER PURCHASES OF EQUITY SECURITIES	16
ITEM 6.	SELECTED FINANCIAL DATA	17
ITEM 7.	MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS	18
ITEM 7A.	QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK	30
ITEM 8.	FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA	31
ITEM 9.	CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON ACCOUNTING AND FINANCIAL DISCLOSURE	32
ITEM 9A.	CONTROLS AND PROCEDURES	32
ITEM 9B.	OTHER INFORMATION	34
ITEM 10.	DIRECTORS, OFFICERS AND CORPORATE GOVERNANCE	34
ITEM 11.	EXECUTIVE COMPENSATION	37
ITEM 12.	SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT AND RELATED STOCKHOLDER MATTERS	41
ITEM 13.	CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS; AND DIRECTOR INDEPENDENCE	43
ITEM 14.	PRINCIPAL ACCOUNTING FEES AND SERVICES	43
ITEM 15.	EXHIBITS, FINANCIAL STATEMENT SCHEDULES	45

INTRODUCTORY NOTE

Except as otherwise indicated by the context, references in this Annual Report on Form 10-K (this “Form 10-K”) to the “Company,” “we,” “us” or “our” are references to the combined business of Joymain International Development Group Inc. (formerly known as Advento Inc.). References to “China” or “PRC” are references to the People’s Republic of China. References to “RMB” are to Renminbi, the legal currency of China, and all references to “$” and dollar are to the U.S. dollar, the legal currency of the United States. In this Form 10-K, unless otherwise specified, all dollar amounts are expressed in United States dollars and all references to “common shares” refer to the common shares in our capital stock.

Special Note Regarding Forward-Looking Statements

This report contains forward-looking statements and information that are based on the beliefs of our management as well as assumptions made by and information currently available to us. Such statements should not be unduly relied upon. When used in this report, forward-looking statements include, but are not limited to, the words “anticipate,” “believe,” “estimate,” “expect,” “intend,” “plan” and similar expressions, as well as statements regarding new and existing products, technologies and opportunities, statements regarding market and industry segment growth and demand and acceptance of new and existing products, any projections of sales, earnings, revenue, margins or other financial items, any statements of the plans, strategies and objectives of management for future operations, any statements regarding future economic conditions or performance, uncertainties related to conducting business in China, any statements of belief or intention, and any statements or assumptions underlying any of the foregoing. These statements reflect our current view concerning future events and are subject to risks, uncertainties and assumptions. There are important factors that could cause actual results to vary materially from those described in this report as anticipated, estimated or expected, including, but not limited to: competition in the industry in which we operate and the impact of such competition on pricing, revenues and margins, volatility in the securities market due to the general economic downturn; Securities and Exchange Commission (the “SEC”) regulations which affect trading in the securities of “penny stocks,” and other risks and uncertainties. Except as required by law, we assume no obligation to update any forward-looking statements publicly, or to update the reasons actual results could differ materially from those anticipated in any forward- looking statements, even if new information becomes available in the future. Depending on the market for our stock and other conditional tests, a specific safe harbor under the Private Securities Litigation Reform Act of 1995 may be available. Notwithstanding the above, Section 27A of the Securities Act of 1933, as amended (the “Securities Act”) and Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”) expressly state that the safe harbor for forward-looking statements does not apply to companies that issue penny stock. Because we may from time to time be considered to be an issuer of penny stock, the safe harbor for forward-looking statements may not apply to us at certain times.

PART I

ITEM 1.

BUSINESS

CORPORATE BACKGROUND

We were incorporated in the State of Nevada on August 4, 2010 under the name Advento, Inc.

We originally planned to market and distribute an assortment of residential and commercial shower cabinets produced by Hangzhou Yongsheng Holdings Co., Ltd in the European and North American market. However, in connection with a change of control transaction that closed on March 12, 2013 which is more fully described below under the section below titled “Change of Control”, we appointed a new executive management team and changed our planned business operations.

Change in Control

On March 12, 2013, pursuant to the terms of a Share Exchange Agreement, Mr. Xijian Zhou acquired an aggregate of 750,000,000 shares of our common stock, representing 82.92% of our issued and outstanding shares as of March 12, 2013. Effective March 12, 2013, (a) Mr. Liangwei Wang resigned as president, secretary, treasurer, and director of our company; (b) Mr. Suqun Lin, was appointed as our sole director, president, secretary and treasurer. Our company did not receive any proceeds from the transaction. In accordance with the terms of the agreement our company at the closing of the agreement had no assets and liabilities. We anticipate to raise additional funding for our operating costs and business development activities. There is no assurance that we will be able to successfully raise funds.

Name Change and Increase of Authorized Shares

On March 21, 2013, we received written consent from the holder of 82.92% of our voting securities and consent from our board of directors approving the name change of our Company from Advento, Inc. to Joymain International Development Group Inc. and effecting a forward split of our issued and outstanding shares on a basis of 300 new shares for 1 old share. Upon the effectiveness of the forward split, our Company’s issued and outstanding shares of common stock increased from 3,015,000 to 904,500,000 shares of common stock, par value $0.001. The board of directors and stockholders also approved to increase our Company’s authorized capital from 75,000,000 to 1,500,000,000 shares of common stock, par value $0.001. The forward split went effective on April 10, 2013 increasing our issued and outstanding shares of common stock from 3,015,000 to 904,500,000 shares. On the same day, our name change went effective and our ticker symbol changed from “ADTO” to “JIDG” . Our current CUSIP number is 48125Q101.

Our Business Plan and Current Status.

We plan to develop, source, market and distribute healthcare related consumer products in the global market and when practicable, acquire an existing company or business in the production or distribution of health consumer goods in the United States. Our principal business objective for the next 12 months and beyond such time will be to achieve long-term growth potential through development and distribution of various healthcare related consumer products and acquisition of a business rather than immediate, short-term earnings through expending our current product market.

The analysis of new business opportunities will be undertaken by or under the supervision of our management. Our company has unrestricted flexibility in seeking, analyzing and participating in potential business opportunities. In its efforts to analyze business opportunities, we will consider the following factors:

	•	Potential for growth, indicated by new technology, anticipated market expansion or new products;
	•	Competitive position as compared to other firms of similar size and experience within the industry segment as well as within the industry as a whole;
	•	Strength and diversity of management, either in place or scheduled for recruitment;

	•	Capital requirements and anticipated availability of required funds, to be provided by the Company or from operations, through the sale of additional securities, through joint ventures or similar arrangements or from other sources;
	•	The cost of participation by our company as compared to the perceived tangible and intangible values and potentials;
	•	The extent to which the business opportunity can be advanced;
	•	The accessibility of required management expertise, personnel, raw materials, services, professional assistance and other required items; and
	•	Other relevant factors.

On June 25, 2014, we entered into a distribution agreement with “Right Fortune to distribute Yolexury and Yolexury Travel Pack, a health juice product which increases energy and stamina, helps to maintain healthy cardio vascular function and promotes healthy digestive system. According to the distribution agreement, we are granted exclusive distribution rights in the Greater China (Mainland China, Hong Kong, Macao and Taiwan) for calendar year 2014. In addition, the term of exclusivity will be automatically renewed annually if we meet the annual Yolexury Minimum Order. The annual Minimum Order for the calendar year 2014 was 400,000 bottles of 750ml Yolexury, which we fulfilled as of October 31, 2014. Accordingly, our agreement has been automatically extended for calendar year 2015. During the years ended April 30, 2016 and 2015, we generated approximately $2.8 million and $1.5 million revenue through sale of the Yolexury products, respectively. We sell our Yolexury and Yolexury Travel Pack products on a wholesale basis and grant distribution rights to a trading company in Hong Kong. This trading company then sells the products and grants distribution rights via an import/export company to distributors in mainland China including Nanjing Joymain who sell products to end users and controlled by our largest shareholder in China. The products are shipped directly to ports designated by our sole customer, a Hong Kong trading company from Right Fortune manufacture factory without going through our warehouse to conserve shipping costs.

We expect that by entering into this distribution agreement, we will start to build up our reputation as a distributor of health products and consumer goods, and expand our distribution network, which will result in positive cash flow.

In May 2014, we acquired a HK trading company, Dao Sheng Trading Limited (“Dao Sheng”) for HK$10,000. Dao Sheng was incorporated in December 2013 and had no assets or liabilities at the time of the acquisition. We also set up Joymain International Intellectual Property Limited in Hong Kong in May 2014. We consider Hong Kong as an ideal location to connect to all Asian markets and it provides a comprehensive and advanced legal system for trading and intellectual property protection.

On May 10, 2014, we entered into a consulting agreement with LP Funding LLC (“LP”), pursuant to which LP agrees to render certain corporate advisory services to us including but not limited to advise us on our business plan and engagement of the financial markets, and conducts due diligence on us including discussions with our management and third party professionals, review of our data and a site visit, and in return, we agree to pay LP an annual fee of $72,000 and issue a total number of 2,390,000 shares of common stock.

During the year ended April 30, 2016, we generated approximately $2.8million of revenue through sale of the Yolexury products to our sole customer in Hong Kong. Fiscal year 2015 was the first year that we started selling Yolexury products. We continue to incur substantial operating loss during fiscal year ended April 30, 2016. These conditions raise substantial doubt about our ability to continue as a going concern. We are currently devoting our efforts to locate new products and acquisition candidates. Our ability to continue as a going concern is dependent upon our ability to generate profitable operations in the future and/or to obtain the necessary financing to meet its obligations and repay its liabilities arising from normal business operations when they come due.

We anticipate that the process of developing healthcare related consumer products and the selection of a business acquisition will be complex and extremely risky. Because of the worldwide stringent economic conditions, rapid technological advances being made in some industries and general shortages of available capital in the market, our management believes that there are numerous firms seeking even the limited additional capital currently available in the market which we would like to have and consider the benefits of becoming a publicly traded corporation. Such perceived benefits of becoming a publicly traded corporation include, among other things, facilitating or improving the terms on which additional equity financing may be obtained, providing liquidity for the principals of and investors in a business, creating a means for providing incentive stock options or similar benefits to key employees, and offering greater flexibility in structuring acquisitions, joint ventures and the like through the issuance of stock. If we are unable to overcome the difficulties of obtaining additional financing and capital from the market, it may be extremely difficult for us to secure business acquisitions that could fuel the organic growth of our business.

Self-underwritten public offering

On July 18, 2014, we filed a registration statement on Form S-1 pursuant to which we sold 145,000 shares of our Common Stock at a fixed price of $0.07 per share (the “Offering”). The Offering was conducted on a self-underwritten, best efforts basis whereby our management and/or controlling shareholders sold 145,000 shares pursuant to the registration statement directly to the public, with no commission or other remuneration payable to them for any shares they may sell. The Form S-1 went effective on August 1, 2014 and expired on November 28, 2014 (the “Public Offering S-1”).

Resale registration statement on Form S-1

On February 11, 2015, we filed a registration statement on Form S-1 File No. 333-202010 (the “Resale S-1”) relates to the resale of up to 51,720,000 shares of our Common Stock including 49,330,000 shares issued at a price of $0.03 per share for a total gross cash proceeds of $1,479,900 in a private placement transaction closed on July 19, 2014 and 2,390,900 shares issued to LP (sometimes also referred as “Consultant” in this report), and this registration statement went effective on April 24, 2015.

Temporary suspension of trading and Internal Investigation

On June 16, 2015, our Board of Directors engaged Hunter Taubman Fischer LLC to commence an internal investigation (the “Internal Investigation”) with regard to the recent rise in the trading price of our common stock and market activity during a period from April 1, 2015 to June 16, 2015 (the “Period in Question”). The Internal Investigation was completed on August 11, 2015.

Some observations reported to our Board of Directors are as follows:

	•	As of August 11, 2015, we have 156,561,019 shares of free trading Common Stock and 963,782,354 shares of restricted Common Stock, totaling 1,120,343,373 shares of issued and outstanding Common Stock.

	•	During the Period in Question, the number of shares of free trading Common Stock increased from 154,654,000 as of April 1, 2015 to 156,296,688 shares as of June 15, 2015, representing an increase of 1,642,688 shares, as reflected in the shareholder lists booked by our transfer agent. During the Period in Question, the Consultant sold an aggregate amount of 1,734,279 shares pursuant to the Resale S-1, as reported by its broker. Although we note there is a slight difference between the increased amount of the free trading shares (1,642,688) and the amount of the shares of Common Stock sold by the Consultant (1,734,279) during the Period in Question, it seem to be reasonable for us to reach a conclusion that shares sold by the Consultant were or constituted large part to the shares which were available for resale during the Period in Question.

	•	We issued a press release on June 13, 2015, stating that we have not “participated in any way or any form of promotion of our shares; nor do we have knowledge of any promotion that may have occurred; and there has been no undisclosed development of our business.” The Internal Investigation has not found or identified any evidence tending to show that our statement made in the press release dated June 13, 2015, was inaccurate, incomplete, or misleading in any manner.

	•	As of the date of the completion of the Internal Investigation, none of our officers, directors or majority shareholders (or members of their families residing in same home) has purchased, sold, transferred, or made any contract, arrangement, understanding or relationship with any other person(s) with respect to any of our securities.

	•	Mr. Xijian Zhou, our majority and controlling shareholder, who holds 750,000,000 shares of Common Stock (66.9% of issued and outstanding as the date of August 11, 2015), is a business man in China with a great deal of notoriety and has a significant number of followers and supporters in China. The Internal Investigation notes that our management believes that demands exist for our Common Stock solely because Mr. Zhou is the controlling shareholder of the Company. Although there is a no conclusion as to whether the shares were purchased based on the confidence in Mr. Zhou by outsiders, the Internal Investigation also notes its observation of continuous interest and active trading in the Company’s Common Stock after the conclusion of the Suspension, despite the fact that (i) we operate at a loss as a going concern and (ii) OTC Markets has discontinued the display of quotes of our Common Stock as a result of the Suspension.

Trading in our Common Stock is currently suspended. Our Board of Directors and management continue to evaluate the situation.

Competition

Currently, we rely on a sole supplier and sole customer for supply and sale of Yolexury and Yolexury Travel Pack. Meanwhile, we are devoting our efforts to locating new healthcare products or consumer goods with high quality and good reputation and seeking acquisition candidates in the U.S. or other developed countries. Once we develop new products, we plan to expand our distribution networks to recruit distributors in China instead of depending on our current sole customer, a Hong Kong trading company.

Our competitors may have better resources, more varieties of products and much stronger distribution networks. Changes in economic conditions affecting our end customers’ purchasing power can occur unpredictably which may have significant effects on the sales of our products as our products are considered high end. We compete directly and indirectly with various other consumer producers that provides different health benefits. However, we believe we provide high quality and consistently reliable products that are made in the U.S. to meet our end customers’ increasing demand for safe, high quality, innovative and foreign made products. We are also taking steps to develop and diversify product lines and expand our distribution channel.

Government Regulations

Regarding distribution of consumer goods, the Chinese government and PRC laws do not require any special and/or additional approvals, permissions or any other qualifications except for the relevant business license.

However, for some of our product offerings, the Chinese government may impose certain regulations on the production, distribution and sales. As such, we will only select suppliers and distributors who are in compliance with all laws and regulations as required by the Chinese government, and who possess all required licenses, permits and approvals as is necessary and required to do business in China.

The products we sell are required to meet the food safety requirements of our end customers’ country. Compliance with the food safety laws did not have a material effect on the capital expenditures, earnings or our competitive position in the fiscal 2016. Because these requirements are subject to change, there can be no guarantee against the possibility of additional costs of compliance. However, we do not expect that the future compliance with the government regulations will have a material effect on our capital expenditures, earnings, or competitive positions in fiscal 2017.

As we currently operate in the U.S., there are no operating activities in our HK subsidiaries, and we do not have any PRC subsidiary, we are not subject to China regulations of foreign investment in PRC operating company, foreign currency exchange, or other regulations applicable to a foreign invested entity. However, if we choose to commence our operation in China, we may become subject to those China laws and regulations applicable to a foreign invested entity.

Employees

We currently have 5 employees included our officers. Our officers are engaged in outside business activities and are anticipated to devote limited time to our business until the acquisition of a successful business opportunity has been identified. Our current officers and director and any other directors and officers hereafter appointed or elected will devote their time to our affairs on an as needed basis, this, depending on the circumstances, could amount to as little as 20 hours per month, or more than 80 hours per month.

Available Information

You are advised to read this Form 10-K in conjunction with other reports and documents that we file from time to time with the SEC. In particular, please read our Quarterly Reports on Form 10-Q and Current Reports on Form 8-K that we file from time to time. You may obtain copies of these reports directly from us or from the SEC at the SEC's Public Reference Room at 100 F. Street, N.E. Washington, D.C. 20549, and you may obtain information about obtaining access to the Reference Room by calling the SEC at 1-800-SEC-0330. In addition, the SEC maintains information for electronic filers at its website http://www.sec.gov.

ITEM 1A. RISK FACTORS

Risks Related to Our Business and Our Industry

We have a limited operating history and a history of operating losses, and expect to incur significant additional operating losses.

We were incorporated in the State of Nevada on August 4, 2010 under the name Advento, Inc. We plan to develop, source, market and distribute healthcare related consumer products in the global market and when practicable, acquire an existing company or business in the production or distribution of health consumer goods in the United States. Our principal business objective for the next 12 months and beyond such time will be to achieve long-term growth potential through development and distribution of various healthcare related consumer products and acquisition of a business rather than immediate, short-term earnings through expending our current product market. Moreover, our future prospects must be considered in light of the uncertainties, risks, expenses, and difficulties frequently encountered by companies in their early stages of operations and competing in new and rapidly developing technology areas. We expect to incur substantial additional operating losses over the next several years as our research, development, and commercial activities increase. The amount of future losses and when, if ever, we will achieve profitability are uncertain.

We may not be able to correctly estimate our future revenues and operating expenses, which could lead to cash shortfalls, and require us to secure additional financing sooner than planned.

We may not correctly predict the amount or timing of future revenues and our operating expenses may fluctuate significantly in the future as a result of a variety of factors, many of which are outside of our control. These factors include:

	•	our expectations regarding revenues from sales of our products and services, and from collaborations with third parties;
	•	the time and cost of obtaining any necessary regulatory approvals;
	•	we may elect to pursue additional research and development programs as part of our long-term business plan;
	•	the cost and time required to create effective sales and marketing capabilities and commercialization strategies;
	•	the expenses we incur to maintain and improve our platform technology;
	•	the costs to attract and retain personnel with the skills required for effective operations; and
	•	the costs of preparing, filing, prosecuting, defending and enforcing patent claims and other patent related costs, including litigation costs and the results of such litigation.

In addition, our budgeted expense levels are based in part on our expectations concerning future revenues from sales of our products and services, and from collaborations with third parties. However, we may not correctly predict the amount or timing of future revenues. In addition, we may not be able to adjust our operations in a timely manner to compensate for any unexpected shortfall in our revenues or we may increase our expenses as part of implementing our long-term business plan. As a result, a significant shortfall in our budgeted revenues or a significant increase in our planned expenses could have an immediate and material adverse effect on our business and financial condition. In such case, we may be required to issue additional equity or debt securities or enter into other commercial arrangements, including relationships with corporate and other partners, sooner than anticipated to secure the additional financial resources to support our development efforts and future operations.

We may need to secure additional financing to support our long-term business plans.

We may require additional funds to support our long-term business plans. We expect that we may be required to issue additional equity or debt securities or enter into other commercial arrangements, including relationships with corporate and other partners, to secure the additional financial resources to support our development efforts and to implement our long-term business plans. Depending upon market conditions, we may not be successful in raising sufficient additional capital on a timely basis, on favorable terms, or at all. Additionally, the issuance of additional equity securities, including securities convertible into or exercisable for our equity securities, would result in the dilution of the ownership interests of our present stockholders. If we fail to obtain sufficient additional financing, or enter into relationships with others that provide additional financial resources, we may not be able to develop our technology and products in accordance with our long-term business plan, and we may be required to delay significantly, reduce the scope of or eliminate one or more of our research or development programs, downsize our general and administrative infrastructure, or seek alternative measures to raise additional funds.

We are subject to risks associated with doing business outside the United States.

We do business with customers outside the United States. We intend to continue to pursue customers and growth opportunities in international markets, and we expect that international revenues may account for a significant percentage of our revenues in the foreseeable future. There are a number of risks arising from our international business, including those related to:

	•	foreign currency exchange rate fluctuations, potentially reducing the United States dollars we receive for sale denominated in foreign currency;
	•	general economic and political conditions in the markets we operate in;
	•	potential increased costs associated with overlapping tax structures;
	•	potential trade restrictions and exchange controls;
	•	more limited protection for intellectual property rights in some countries;
	•	difficulties and costs associated with staffing and managing foreign operations;
	•	unexpected changes in regulatory requirements;
	•	the difficulties of compliance with a wide variety of foreign laws and regulations; and
	•	longer accounts receivable cycles in certain foreign countries, whether due to cultural differences, exchange rate fluctuation or other factors.

These risks, individually or in the aggregate, could have an adverse effect on our results of operations and financial condition. For example, we are subject to compliance with the United States Foreign Corrupt Practices Act and similar anti-bribery laws, which generally prohibit companies and their intermediaries from making improper payments to foreign government officials for the purpose of obtaining or retaining business. While our employees are required to comply with these laws, we cannot be sure that our internal policies and procedures will always protect us from violations of these laws, despite our commitment to legal compliance and corporate ethics. The occurrence or allegation of these types of risks may adversely affect our business, performance, prospects, value, financial condition, and results of operations.

Risks Related to Our Common Stock and Liquidity Risks

Our Common Stock has been suspended trading since June 2015 and there is no assurance that our Common Stock will resume trading in the near future.

There is limited trading history in our common stock, and the trading for our common stock has been suspended from OTC market since June 2015. There is no assurance that our common stock will resume trading, or if trading is resumed, we will have an active market in our common stock in the future. As a result, an investor may find it difficult to dispose of our common stock on the timeline and at the volumes they desire. This factor significantly limits the liquidity of our common stock, and may have a material adverse effect on the market price of our common stock and on our ability to raise additional capital.

Compliance with the reporting requirements of federal securities laws can be expensive.

We are a public reporting company in the United States, and accordingly, subject to the information and reporting requirements of the Exchange Act and other federal securities laws, including the compliance obligations of the Sarbanes-Oxley Act. The costs of complying with the reporting requirements of the federal securities laws, including preparing and filing annual and quarterly reports and other information with the SEC and furnishing audited reports to stockholders, can be substantial.

On June 15, 2015, trading in our Common Stock was temporarily suspended by the Securities and Exchange Commission (the “Commission” ) due to unexplained market activity. As a result, trading in our Common Stock has been suspended since June 15, 2015. On June 16, 2015, our Board of Directors engaged Hunter Taubman Fischer LLC to commence the Internal Investigation. The Internal Investigation was completed on August 11, 2015. In May 2016, we received certain informal inquiry from the Commission regarding trading activity in our common stock and the Company is currently in the process of responding to such inquiry. The inquiry requires that we provide certain categories of documents to the Commission. The Commission indicated in its inquiry that it should not be construed as an indication that any violation of any federal securities laws has occurred or as a reflection upon the merits of any person, company, or securities involved. The inquiry is a confidential non-public fact finding request. It is not possible at this time to predict the outcome of the inquiries, including whether or when any proceedings might be initiated, when these matters may be resolved or what, if any, penalties or other remedies may be imposed. We have been, and intend to continue, voluntarily cooperating fully with the SEC. The scope and outcome of this matter cannot be determined at this time. We have expended significant resources to the Internal Investigation and responding to the Commission’s inquiry. Failure to resolve such matters favorably could harm tradability of our common stock and our reputation significantly and could result in a loss of your investment in our stock.

The price of our common stock may continue to be volatile, which could lead to losses by investors and costly securities litigation.

The trading price of our common stock is likely to be highly volatile and could fluctuate in response to factors such as:

	•	actual or anticipated variations in our operating results;
	•	regulatory actions regarding our products or services;
	•	reduced government funding for research and development activities;
	•	announcements by us or our competitors of significant acquisitions, strategic partnerships, joint ventures or capital commitments;
	•	adoption of new accounting standards affecting our industry;
	•	additions or departures of key personnel;
	•	introduction of new products by us or our competitors;
	•	sales of our common stock or other securities in the open market;
	•	degree of coverage of securities analysts and reports and recommendations issued by securities analysts regarding our business;
	•	volume fluctuations in the trading of our common stock; and
	•	other events or factors, many of which are beyond our control.

The stock market is subject to significant price and volume fluctuations. In the past, following periods of volatility in the market price of a company’s securities, securities class action litigation has often been initiated against such a company. Litigation initiated against us, whether or not successful, could result in substantial costs and diversion of our management’s attention and resources, which could harm our business and financial condition.

Investors may experience dilution of their ownership interests because of the future issuance of additional shares of our capital stock.

We are authorized to issue 1,500,000,000 shares of common stock. As of July 29, 2016, there were an aggregate of 1,120,343,373 shares of our common stock issued and outstanding on a fully diluted basis and no shares of preferred stock outstanding. We do not have any exercisable options or warrants outstanding.

In the future, we may issue additional authorized but previously unissued equity securities, resulting in the dilution of the ownership interests of our present stockholders. We may also issue additional shares of our capital stock or other securities that are convertible into or exercisable for our capital stock in connection with presently outstanding warrants, hiring or retaining employees, future acquisitions, future sales of our securities for capital raising purposes, or for other business purposes. The future issuance of any such additional shares of capital stock may create downward pressure on the trading price of our common stock. There can be no assurance that we will not be required to issue additional shares, warrants or other convertible securities in the future in conjunction with any capital raising efforts.

Risks related to Doing Business in the Greater China Area

Our operations are subject to risks associated with emerging markets.

The Chinese economy is not well established and is only recently emerging and growing as a significant market for consumer goods and services. Accordingly, there is no assurance that the market will continue to grow. Perceived risks associated with investing in the greater China area, or a general disruption in the development of the greater China’s markets could materially and adversely affect the business, operating results and financial condition of the Company.

The PRC government has the ability to exercise significant influence and control over our operations in the greater China area.

There can be no assurance that greater China area’s economic, political or legal systems will not develop in a way that becomes detrimental to our business, results of operations and financial condition. Our activities may be materially and adversely affected by changes in the greater China’s economic and social conditions and by changes in the policies of the government, such as measures to control inflation, changes in the rates or method of taxation and the imposition of additional restrictions on currency conversion.

Additional factors that we may experience in connection with having operations in China that may adversely affect our business and results of operations include:

	•	our inability to enforce or obtain a remedy under any material agreements;
	•	PRC restrictions on foreign investment that could impair our ability to conduct our business or acquire or contract with other entities in the future;
	•	restrictions on currency exchange that may limit our ability to use cash flow most effectively or to repatriate our investment;
	•	fluctuations in currency values;
	•	cultural, language and managerial differences that may reduce our overall performance; and
	•	political instability in the greater China area.

Cultural, language and managerial differences may adversely affect our overall performance.

We have experienced difficulties in assimilating cultural, language and managerial differences with our subsidiaries in the greater China area. Personnel issues have developed in consolidating management teams from different cultural backgrounds. In addition, language translation issues from time to time have caused miscommunications. These factors make the management of our operations in the greater China area more difficult. Difficulties in coordinating the efforts of our U.S.-based staff with our China-based management team may cause our business, operating results and financial condition to be materially and adversely affected.

We may not be able to enforce our rights in the greater China area given certain features of its legal and judicial system.

The products we sold are required to meet the food safety requirements of our end customers’ country. Compliance with the food safety laws did not have a material effect on the capital expenditures, earnings or our competitive position in the fiscal 2016. Because these requirements are subject to change, there can be no guarantee against the possibility of additional costs of compliance. However, we do not expect that the future compliance with the government regulations will have a material effect on our capital expenditures, earnings, or competitive positions in fiscal 2017.

As we currently operate in the U.S., there are no operating activities in our Hong Kong subsidiaries, and we do not have any PRC subsidiary, we are not subject to China regulations of foreign investment in PRC operating company, foreign currency exchange, or other regulations applicable to a foreign invested entity. However, if we choose to commence our operation in China, we may become subject to those China laws and regulations applicable to a foreign invested entity.

ITEM 1B. UNRESOLVED STAFF COMMENTS

None.

ITEM 2.

PROPERTIES

Our principal executive office is located at 2719 Hollywood Blvd. Hollywood, FL 33020. Our telephone number is 1-786-232-3083. We pay a monthly lease of $100 for the use of the office and the lease can be terminated with a 30 days advance notice. We do not own any real estate or other properties.

ITEM 3.

LEGAL PROCEEDINGS

We know of no material, existing or pending legal proceedings against our company, nor are we involved as a plaintiff in any material proceeding or pending litigation. There are no proceedings in which any of our directors, officers or affiliates, or any registered or beneficial stockholder, is an adverse party or has a material interest adverse to our interest.

ITEM 4.

MINE SAFETY DISCLOSURES

Not applicable.

PART II

ITEM 5.

MARKET FOR REGISTRANT’S COMMON EQUITY, RELATED STOCKHOLDER MATTERS AND ISSUER PURCHASES OF EQUITY SECURITIES

Market Information

Our common stock was quoted on the OTC Bulletin Board under the symbol “JIDG” until June 14, 2015. On June 15, 2015, trading in our Common Stock was temporarily suspended by the Commission due to unexplained market activity. As a result, trading in our Common Stock has been suspended since then. As a result of the suspension, OTC Markets has discontinued the display of quotes of our common stock. Management continues to evaluate the situation.

		High		Low
Fiscal 2016
May 1, 2015 through July 31, 2015	$	8.53	$	0.44
August 1, 2015 through October 31, 2015	$	*	$	*
November 1, 2015through January 31, 2016	$	*	$	*
February 1, 2016 through April 30, 2016	$	*	$	*

Fiscal 2015
May 1, 2014 through July 31, 2014	$	-	$	-
August 1, 2014 through October 31, 2014	$	-	$	-
November 1, 2014 through January 31, 2015	$	-	$	-
February 1, 2015 through April 30, 2015	$	4.5	$	0.08

*Trading of the Company’s stock was suspended and there was no active quotation during the period.

Currently there is no public market for our common shares. Our common shares previously traded on the OTC Bulletin Board under the symbol “JIDG” but OTC Markets has discontinued the quotes of our common shares.

Number of Holders

As of July 29, 2016, the 1,120,343,373 issued and outstanding shares of common stock were held by a total of 897 shareholders record. This number excludes any estimate by us of the number of beneficial owners of shares held in street name, the accuracy which cannot be guaranteed.

Our registered transfer agent for our common stock is Island Stock Transfer, 15500 Roosevelt Boulevard, Suite 301, Clearwater, 33760, Telephone (727) 289-0010.

Dividends

No cash dividends were paid on our shares of common stock during the fiscal years ended April 30, 2016 and 2015. We have not paid dividends since our inception and do not foresee declaring any cash dividends on our common stock in the foreseeable future.

We do not intend to issue any cash dividends in the future. We intend to retain earnings, if any, to finance the development expansion of our business.

However, it is possible that our management may decide to declare a stock dividend in the future. Our future dividend policy subject to the discretion of our board of directors and will be contingent upon future earnings, if any, our financial condition, capital requirements, general business conditions and other factors.

Recent Sales of Unregistered Securities; Use of Proceeds from Registered Securities

We did not sell any equity securities which were not registered under the Securities Act during the fiscal year ended April 30, 2016.

Equity Compensation Plans

We do not have in effect any compensation plans under which our equity securities are authorized for issuance and we do not any outstanding stock options.

Purchase of our Equity Securities by the Issuer and Affiliated Purchasers

We did not purchase any of our shares of common stock or other securities during our fiscal year ended April 30, 2016.

ITEM 6.

SELECTED FINANCIAL DATA

The following tables set forth certain of our selected consolidated financial data as of the dates and for the years indicated. Historical results are not necessarily indicative of the results to be expected for any future period. The following selected consolidated financial information was derived from our fiscal year end consolidated financial statements.

Years ended April 30,
		2016			2015			2014
Summary of Operations
Revenues	$	2,765,801		$	1,505,516		$	-
Cost of revenues		2,548,037			1,377,855			-
Gross Profit		217,764			128,661			-
Operating Expenses		(326,572	)		(13,536,491	)		(167,465	)
Other Income		1,111			13,896			1,806
Net loss	$	(107,697	)	$	(13,393,934	)	$	(165,659	)
Basic and Diluted:
Loss per common share		a		$	(0.01	)		a

Balance Sheet Data
Working capital	$	949,394		$	1,056,691		$	1,250,105
Total assets	$	1,436,681		$	2,533,281		$	1,304,603
Total liabilities	$	486,132		$	1,475,035		$	52,543

a= Less than ($0.01) per share

ITEM 7.

MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

The following discussion should be read in conjunction with our financial statements, including the notes thereto, appearing elsewhere in this annual report. Management’s Discussion and Analysis of Financial Condition and Results of Operations (“MD&A”) includes comparisons of the years ended April 30, 2016 , 2015 and 2014. The following discussion contains forward-looking statements that reflect our plans, estimates and beliefs. Our actual results could differ materially from those discussed in the forward looking statements. Our audited financial statements are stated in United States Dollars and are prepared in accordance with United States Generally Accepted Accounting Principles.

Overview

We were incorporated in the State of Nevada on August 4, 2010 under the name Advento, Inc with an original plan to market and distribute an assortment of residential and commercial shower cabinets produced by Hanzhou Yongsheng Holdings Co., Ltd in the European and North American markets. On March 12, 2013, Mr. Xijian Zhou acquired a total of 750,000,000 shares of our common stock from Mr. Liangwei Wang, a former major shareholder of us, for a total consideration of $306,680, representing 82.92% of our issued and outstanding shares as of March 12, 2013 (the “Transfer”). As of the date of this report, Mr. Xijian Zhou holds 66.9% of our issued and outstanding shares. In connection with the change of control, we changed our business operation plan to develop, source, market and distribute healthcare related consumer products in the global market and possibly acquire an existing target company or business in the related field which operates in the United States. Our principal business objective for the next 12 months and beyond such time will be to achieve long-term growth potential through development of various healthcare related consumer products and acquisition of a business rather than immediate, short-term earnings.

	•	Potential for growth, indicated by new technology, anticipated market expansion or new products;
	•	Competitive position as compared to other firms of similar size and experience within the industry segment as well as within the industry as a whole;
	•	Strength and diversity of management, either in place or scheduled for recruitment;
	•	Capital requirements and anticipated availability of required funds, to be provided by the Company or from operations, through the sale of additional securities, through joint ventures or similar arrangements or from other sources;

	•	The cost of participation by our company as compared to the perceived tangible and intangible values and potentials;
	•	The extent to which the business opportunity can be advanced;
	•	The accessibility of required management expertise, personnel, raw materials, services, professional assistance and other required items; and
	•	Other relevant factors.

Recent Events

Business updates

To facilitate our growth, we acquired a HK trading company, Dao Sheng Trading Limited for HK$10,000 and set up Joymain International Intellectual Property Limited in Hong Kong in May 2014. We consider Hong Kong as an ideal location to connect to all Asian markets and it provides a comprehensive and advanced legal system for trading and intellectual property protection. We have not had operating activities in our HK subsidiaries in fiscal year 2016

We have started generating revenue in the fiscal year 2015. However, we still continue to incur substantial operating loss. These conditions raise substantial doubt about our ability to continue as a going concern. We are currently devoting our efforts to locating new products and acquisition candidates. Our ability to continue as a going concern is dependent upon our ability to develop additional sources of capital, to locate and complete a merger with another company, and ultimately, to achieve profitable operations.

RESULTS OF OPERATIONS

We have just started generating revenue recently and incurred recurring losses to date. Our financial statements have been prepared assuming that we will continue as a going concern and, accordingly, do not include adjustments relating to the recoverability and realization of assets and classification of liabilities that might be necessary should we be unable to continue in operation. We expect we will require additional capital to meet our long term operating requirements. We expect to raise additional capital through, among other things, the sale of equity or debt securities in funding our planned business, although no such sales can be guaranteed to occur on terms favorable to us, if at all. The accompanying condensed consolidated financial statements do not include any adjustments related to the recoverability or classification of asset-carrying amounts or amounts and classifications of liabilities that may result should the Company be unable to continue as a going concern.

Consolidated Statement of Operations and Supplemental Information

							Years ended April 30,
					Change								Change
		2016		$			%			2015		$		%		2014
Revenues	$	2,765,801		$	1,260,285		84		$	1,505,516		$	1,505,516		$	-
Cost of revenues		2,548,037			1,170,182		85			1,377,855			1,377,855	100		-
Gross Profit		217,764			89,103		69			128,661			128,661	100		-
Operating Expenses
General and administrative expenses		326,572			(91,649	)	(22	)		418,221			250,756	150		167,465
Business development expenses		-			(13,118,270	)	(100	)		13,118,270			13,118,270	100		-
Other Income		1,111			(12,785	)	(92	)		13,896			12,090	669		1,806
Provision for income taxes		-			-		-			-			-	-		-
Net loss	$	(107,697	)	$	(13,286,237	)	(99	)	$	(13,393,934	)	$	13,228,275	7,985	$	(165,659	)

Results of Operations - Year Ended April 30, 2016 as Compared to Year Ended April 30, 2015

We have limited operational history. Our ability to generate any revenues in the next 12 months continues to be uncertain.

Revenues. During the year ended April 30, 2016, we generated $2,765,801 revenue through sale of the Yolexury products to our sole customer in Hong Kong as compared to $1,505,516 for the year ended April 30, 2015, an increase of $1,260,285 or 84%. We had a full year sales in the year ended April 30, 2016 as compared to the six months sales in the year ended April 30, 2015. Fiscal year 2015 was the first year we started selling Yolexury products and we are currently in the process of developing other customers and products.

Gross Profit. Gross profit amounted to $217,764 for the year ended April 30, 2016 as compared to $128,661 for the year ended April 30, 2015, an increase of $89,103 or 69%. The increase was due to increase in sales in fiscal year 2016.

Net Loss. Our net loss for the fiscal year ended April 30, 2016 was $107,697 compared to a net loss of $13,393,934 for the year ended April 30, 2015, a decrease of $13,286,237 or 99%. The decrease in net loss was primarily because we did not incur business development expenses for the year ended April 30, 2016 as compared to approximately $13.1 million business development expenses incurred for the year ended April 30, 2015, and a decrease in professional fees of approximately $88,000 in fiscal year 2016.

Professional Fees. During the year ended April 30, 2016, we incurred $198,578 of professional fees consisting of auditing, accounting, business advisory, legal and filing fees associated with the filings with the Securities and Exchange Commission (“SEC”) and internal investigation legal fees. During the year ended April 30, 2015, our company incurred $286,553 of professional fees consisting of auditing, accounting, business advisory, legal and filing fees associated with our company’s name change, stock split, and filing of period reports with SEC. The decrease of $87,955 or approximately 31% was primarily because we did not incur fees for hiring a financial consultant in fiscal year 2016.

Other General and Administrative Expenses. Other general and administrative expenses totaled $127,994 for the year ended April 30, 2016, as compared to $131,668 for the year ended April 30, 2015, a decrease of $3,674 or approximately 3%. Other general and administrative expenses for the years ended April 30, 2016 and 2015 consisted of the following:

		Year Ended		Year Ended
		April 30, 2016		April 30, 2015
Travel and entertainment	$	13,541	$	12,840
Payroll and related benefits		101,497		108,170
Others		12,956		10,658
Total	$	127,994	$	131,668

Travel and entertainment expense for the year ended April 30, 2016 increased by $4701, or 5%, as compared to the year ended April 30, 2015. The increase was primarily attributable to the increased spending in our corporate travels for general business development purposes.

Payroll and related benefits for the year ended April 30, 2016 decreased by $6,673, or 6%, as compared to the year ended April 30, 2015. The decrease was primarily due to reduced work hours for our part time staff in fiscal 2016. Other general and administrative expenses for the year ended April 30, 2016 increased by $2,298, or 22% as compared to the year ended April, 30, 2015. The increase was primarily due to the increased office rent in fiscal year 2016.

Business Development Expenses. For the year ended April 30, 2016, we did not have any business development expenses. In January 2015, we issued a total of 163,978,373 shares of common stock to our thirty four (34) distribution and development partners. The shares were valued at $0.08 per share and we recorded stock-based business development expenses of $13,118,270.

Other Income. Other income totaled $1,111 for the year ended April 30, 2016 primarily consisted of interest income of $955 and other income of $156, which consisted of unrealized loss on marketable securities of $3,624 and other income of $3,780. Other income totaled $13,896 for the year ended April 30, 2015 primarily consisted of interest income of $1,532 and unrealized gain on marketable securities of $9,857 and other income of $2,507.

Results of Operations - Year Ended April 30, 2015 as Compared to Year Ended April 30, 2014

		Years ended 31April 30,						Increase/	%
		2015			2014			(decrease)	change
Revenues	$	1,505,516		$	-		$	1,505,516	N/A
Cost of revenues		1,377,855			-			1,377,855	N/A
Gross Profit		128,661			-			128,661	N/A
Operating Expenses
General and administrative expenses		418,221			167,465			250,756	150
Business development expenses		13,118,270			-			13,118,270	N/A
Other Income		13,896			1,806			12,090	669
Provision for income taxes		-			-			-	N/A
Net loss	$	(13,393,934	)	$	(165,659	)	$	13,228,275	7,985

We have limited operational history. Our ability to generate any revenues in the next 12 months continues to be uncertain.

Revenues. During the year ended April 30, 2015, we generated $1,506,516 revenue through sale of the Yolexury products to our sole customer in Hong Kong. Fiscal year 2015 was the first year we started selling Yolexury products and we are currently in the process of developing other customers and products. We did not generate any revenues for the year ended April 30, 2014.

Gross Profit. Gross profit amounted to $128,661 for the year ended April 30, 2015. We did not incur any revenue for the year ended April 30, 2014.

Net Loss. Our net loss for the fiscal year ended April 30, 2015 was $13,393,934 compared to a net loss of $165,659 for the year ended April 30, 2014. The increase in net loss was due to the approximately $13.1 million business development expenses incurred as a result of the 163,978,373 shares issued to our thirty four (34) distribution and development partners.

Professional Fees. During the year ended April 30, 2015, we incurred $286,553 of professional fees consisting of auditing, accounting, business advisory, legal and filing fees associated with the filings with the Securities and Exchange Commission (“SEC”). During the year ended April 30, 2014, our company incurred $113,437 of professional fees consisting of auditing, accounting, business advisory, legal and filing fees associated with our company’s name change, stock split, and filing of period reports with SEC. The increase of $173,116 or approximately 152.6% was primarily because of fees incurred for hiring a consultant and expenses related to the filing of two registration statements in fiscal year 2015.

Other General and Administrative Expenses. Other general and administrative expenses totaled $131,668 for the year ended April 30, 2015, as compared to $54,028 for the year ended April 30, 2014, an increase of $77,640 or approximately 143.7%. Other general and administrative expenses for the years ended April 30, 2015 and 2014 consisted of the following:

		Year Ended		Year Ended
		April 30, 2015		April 30, 2014
Travel and entertainment	$	12,840	$	17,439
Payroll and related benefits		108,170		33,405
Others		10,658		3,184
Total	$	131,668	$	54,028

Travel and entertainment expense for the year ended April 30, 2015 decreased by $4,599, or 26.4%, as compared to the year ended April 30, 2014. The decrease was primarily attributable to the decreased spending in our travel as we did not have many activities in connection with on-site communicating and discussing with potential product suppliers and acquiring potential business targets in the last two quarters of fiscal 2015.

Payroll and related benefits for the year ended April 30, 2015 increased by $74,765, or 223.8%, as compared to the year ended April 30, 2014. In order to support our business development activities, we hired one employee and two officers during the year ended April 30, 2015. We only had one employee in the U.S. and one officer during the year ended April 30, 2014.

Other general and administrative expenses for the year ended April 30, 2015 increased by $7,474, or 234.7% as compared to the year ended April, 30, 2014. The increase was caused by the increased business activities.

Business Development Expenses. In January 2015, we issued a total of 163,978,373 shares of common stock to our thirty four (34) distribution and development partners. The shares were valued at $0.08 per share and we recorded stock-based business development expenses of $13,118,270. For the year ended April 30, 2014, we did not have business development expenses.

Other Income. Other income totaled $13,896 for the year ended April 30, 2015 primarily consisted of interest income of $1,532 and unrealized gain on marketable securities of $9,857 and other income of $2,507. For the year ended April 30, 2014, we had interest income of $1,806.

Liquidity and Capital Resources

The following table sets forth a summary of our approximate cash flows for the periods indicated:

										As of April 30,
					Change								Change
		2016		$			%			2015		$			%			2014
Net cash provided by (used in) operating activities	$	141,012		$	179,455		467		$	(38,443	)	$	(119,295	)	(76	)	$	(157,738	)
Net cash provided by (used in) investing activities	$	100,409			450,409		129		$	(350,000	)		347,948		16,957		$	(2,052	)
Net cash (used in) provided by financing activities	$	(3,294	)		(31,172	)	(90	)	$	(34,466	)		(1,496,004	)	(102	)	$	1,461,538

Our cash and cash equivalents is our principal source of liquidity. At April 30, 2016, our current assets were $1,435,526, compared to $2,531,726 in current assets as of April 30, 2015. Current assets at April 30, 2016 were comprised of $1,116,966 in cash, $62,736 in advance to suppliers and $255,824 in marketable securities which consist of mutual funds as compared to $878,839 in cash, $1,293,030 in advance to suppliers and $359,857 in marketable securities which consist of certificates of deposits and mutual funds at April 30 2015. As of April 30, 2016, our current liabilities were $486,132 as compared to $1,475,035 at April 30, 2015. Current liabilities at April 30, 2016 were comprised of $235 in due to related parties, $5,299 in accounts payable, $428,781 in advance from customers and $51,817 in other payables as compared to $3,529 in due to related parties, $24,726 in accounts payable, $1,423,031 in advance from customers and $23,749 in other payables at April 30, 2015.

Stockholders’ equity was $950,549 as of April 30, 2016 compared to $1,058,246 as of April 30, 2015.

We intend to finance operating costs over the next twelve months with existing cash on hand and loans from our major shareholder. We will need to depend on outside capital for our future business developments. Such outside capital will include proceeds from the issuance of equity securities and may include commercial borrowing. We cannot guarantee that actions presently being taken to implement our strategic plans will provide the opportunity for us to continue our business operations.

Cash Flows Provided By (Used In) Operating Activities

For the year ended April 30, 2016, net cash flow provided by operating activities was $141,012, which primarily reflected a net loss of $107,697, and the add-back of non-cash items of depreciation and amortization of $400, unrealized gain on marketable securities, net of investment management fees of $3,624 and changes in operating assets and liabilities primarily consisting of a decrease in advance to suppliers of $1,230,294, a decrease in accounts payable of $19,427, a decrease in advance from customer of $994,250 and an increase of other payable of $28,068. For the year ended April 30, 2015, net cash flow used in operating activities was $38,443 primarily reflecting a net loss of $13,393,934, and the add-back of non-cash items of depreciation and amortization of $400, stock compensation to a consultant of $71,700, stock issued for business development expenses of $13,118,270, expenses paid by related parties of $8,290 and unrealized gain on marketable securities, net of investment management fees of $9,857, and changes in operating assets and liabilities primarily consisting of an increase in advance to suppliers of $1,293,030, an increase in accounts payable of $12,038, an increase in advance from customers of $1,423,031, and an increase in other payables of $23,749. For the fiscal year ended April 30, 2014, net cash flows used in operating activities was $157,738, consisting of a net loss of $165,659, the add-back of non-cash item of deprecation of $97, an increase in accounts payable of $6,779, and a decrease in prepaid expenses of $1,045.

Cash Flows Provided By (Used In) Investing Activities

We had proceeds from sell of marketable securities of $100,409 for the year ended April 30, 2016. We purchased marketable securities of $350,000 for the year ended April 30, 2015. Net cash flow used in investing activities reflects the purchase of property and equipment of $2,052 for the year ended April 30, 2014.

Cash Flows from Financing Activities

We have financed our operations primarily from either advances from related parties or the issuance of equity. During the year ended April 30, 2016, we had repayments to a related party of $3,294. For the year ended April 30, 2015, we had proceeds from issuance of common stock of $10,150, received advances from related parties of $60 and made repayment to related parties of $44,676. For the year ended April 30, 2014, net cash provided by financing activities was $1,461,538 including advances from related parties of $60,782, proceeds from issuance of common stock of $1,479,900, and offset by repayments of shareholders loans of $48,040 and payments of common stock offering costs of $31,104.

We expect our capital expenditures for the next twelve months will continue to increase as we expect to incur additional costs for regulatory compliances purposes and operations. We believe that we will need additional outside capital investments to meet our anticipated cash requirements for the next twelve months.

As our current operation generates limited cash flow for us, we expect to depend on outside capital for our future operations. Such outside capital may include proceeds from advances from related parties, the issuance of equity securities and may include commercial borrowing. There can be no assurance that capital will be available as necessary to meet these development costs or, if the capital is available, that it will be on terms acceptable to us.

Critical Accounting Policies

Basis of Presentation.

The consolidated financial statements of the Company have been prepared in accordance with generally accepted accounting principles in the United States of America and are presented in US dollars. The Company’s consolidated financial statements included the financial statements of its wholly-owned subsidiaries, Dao Sheng and Joymain International Intellectual Property Limited. All significant intercompany accounts and transactions have been eliminated in consolidation.

Going Concern

The consolidated financial statements have been prepared on a going concern basis which assumes the Company will be able to realize its assets and discharge its liabilities in the normal course of business for the foreseeable future. The Company has incurred losses since inception resulting in an accumulated deficit of $14,606,652 as of April 30, 2016 and further losses are anticipated in the development of its business, which raise substantial doubt about the Company’s ability to continue as a going concern. The ability to continue as a going concern is dependent upon the Company generating profitable operations in the future and/or to obtain the necessary financing to meet its obligations and repay its liabilities arising from normal business operations when they come due. Management intends to finance operating costs over the next twelve months with existing cash on hand and loans from directors and or sale of common stock.

The Company expects to depend on outside capital for its future business developments. Such outside capital may include proceeds from the issuance of equity securities and may include commercial borrowing. There can be no assurance that capital will be available as necessary to meet these development costs or, if the capital is available, that it will be on terms acceptable to the Company.

The issuances of additional equity securities by the Company may result in a significant dilution in the equity interests of its current stockholders. Obtaining commercial loans, assuming those loans would be available, will increase the Company's liabilities and future cash commitments.

However, there can be no assurance that these arrangements will be sufficient to fund its ongoing capital expenditures, working capital, and other cash requirements. The outcome of these matters cannot be predicted at this time.

There can be no assurance that any additional financings will be available to the Company on satisfactory terms and conditions, if at all. In the event we are unable to continue as a going concern, we may elect or be required to seek protection from our creditors by filing a voluntary petition in bankruptcy or may be subject to an involuntary petition in bankruptcy. To date, management has not considered this alternative, nor does management view it as a likely occurrence.

The accompanying consolidated financial statements do not include any adjustments related to the recoverability or classification of asset-carrying amounts or the amounts and classification of liabilities that may result should the Company be unable to continue as a going concern.

Cash and Cash Equivalents

The Company considers all highly liquid instruments with a maturity of three months or less at the time of issuance to be cash equivalents. The Company maintains cash and cash equivalents with a financial institution in the U.S. Cash and cash equivalents consisted of cash and money market accounts at April 30, 2016. Financial instruments that potentially subject the Company to concentration of credit risk consist of cash accounts in a financial institution which, at times may exceed the Federal depository insurance coverage of $250,000. As of April 30, 2016 and 2015, the Company had approximately $867,000 and $629,000 in excess of the federally-insured limits, respectively. The Company has not experienced losses on these accounts as of the date of this report.

Use of Estimates and Assumptions

The preparation of consolidated financial statements in conformity with accounting principles generally accepted in the United States requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Significant estimates include the useful life of property and equipment, valuation of deferred tax assets, and the value of stock-based compensation. Actual results could differ from those estimates.

Inventories

Inventories, consisting of the Company’s Yoluxey products, are stated at the lower of cost or market (estimated net realizable value) utilizing the weighted average method. An allowance is established when management determines that certain inventories may not be saleable. If inventory costs exceed expected market value due to obsolescence or quantities in excess of expected demand, the Company will record reserves for the difference between the cost and the market value. These reserves are recorded based on estimates. The Company works with its vendor and customer to arrange the drop shipments for its inventories and the inventories are shipped directly to the ports designated by the Company’s customer from the manufacture factory without going through the Company’s warehouse to conserve shipping costs. As of April 30, 2016 and 2015, the Company did not have inventories on hand and there is no reserve for obsolete or slow-moving inventories necessary.

Advance to Suppliers

The Company periodically makes advances to vendors for purchases of products for resale, and records these purchases as advance to suppliers.

Fair Value of Financial Instruments

The Company adopted ASC 820, Fair Value Measurements and Disclosure (“ASC 820”) for assets and liabilities measured at fair value on a recurring basis. ASC 820 establishes a common definition for fair value to be applied to existing generally accepted accounting principles that require the use of fair value measurements, establishes a framework for measuring fair value and expands disclosure about such fair value measurements. The adoption of ASC 820 did not have an impact on the Company’s financial position or operating results, but did expand certain disclosures.

ASC 820 defines fair value as the price that would be received upon sale of an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. Additionally, ASC 820 requires the use of valuation techniques that maximize the use of observable inputs and minimize the use of unobservable inputs. These inputs are prioritized below:

Level 1: Observable inputs such as quoted market prices in active markets for identical assets or liabilities
Level 2: Observable market-based inputs or unobservable inputs that are corroborated by market data
Level 3: Unobservable inputs for which there is little or no market data, which require the use of the reporting entity’s own assumptions.

The following table sets forth by level within the fair value hierarchy of the Company’s financial assets that were accounted for at fair value on a recurring basis as of April 30, 2016 and 2015:

				April 30, 2016								April 30, 2015
		Level 1		Level 2		Level 3		Total		Level 1		Level 2		Level 3		Total
Marketable securities	$	255,824	$	—	$	—	$	255,824	$	359,857	$	—	$	—	$	359,857
Total assets at fair value	$	255,824	$	—	$	—	$	255,824	$	359,857	$	—	$	—	$	359,857

The carrying values of prepaid expenses, advance to suppliers, accounts payables, due to related parties, advance from customer and other payables approximate their fair values due to the short maturities of these instruments.

Stock-based Compensation

Stock-based compensation is accounted for based on the requirements of the Share-Based Payment topic of ASC Topic 718 which requires recognition in the financial statements of the cost of employee and director services received in exchange for an award of equity instruments over the period the employee or director is required to perform the services in exchange for the award (presumptively, the vesting period). The Financial Accounting Standards Board (“FASB”) also requires measurement of the cost of employee and director services received in exchange for an award based on the grant-date fair value of the award.

Pursuant to ASC Topic 505-50, for share-based payments to consultants and other third-parties, compensation expense is determined at the “measurement date.” The expense is recognized over the vesting period of the award. Until the measurement date is reached, the total amount of compensation expense remains uncertain. The Company records compensation expense based on the fair value of the award at the reporting date. The awards to consultants and other third-parties are then revalued, or the total compensation is recalculated, based on the then current fair value, at each subsequent reporting date.

To date, the Company has not adopted a stock option plan and has not granted any stock options.

Income Taxes

The Company has adopted Accounting Standards Codification subtopic 740-10, Income Taxes (“ASC 740-10”) which requires the recognition of deferred tax liabilities and assets for the expected future tax consequences of events that have been included in the financial statement or tax returns. Under this method, deferred tax liabilities and assets are determined based on the difference between financial statements and tax basis of assets and liabilities using enacted tax rates in effect for the year in which the differences are expected to reverse. Valuation allowances are recorded to reduce the deferred tax assets to an amount that it is more likely than not be realized.

We apply the provisions of ASC 740-10-50, “Accounting for Uncertainty in Income Taxes”, which provides clarification related to the process associated with accounting for uncertain tax positions recognized in our consolidated financial statements. Audit periods remain open for review until the statute of limitations has passed. The completion of review or the expiration of the statute of limitations for a given audit period could result in an adjustment to the Company’s liability for income taxes. Any such adjustment could be material to the Company’s results of operations for any given quarterly or annual period based, in part, upon the results of operations for the given period. As of April 30, 2016, the Company had no uncertain tax positions, and will continue to evaluate for uncertain positions in the future.

Basic and Diluted Loss Per Share

The Company computes loss per share in accordance with “ASC-260”, “Earnings per Share” which requires presentation of both basic and diluted earnings per share on the face of the statement of operations. Basic loss per share is computed by dividing net loss available to common shareholders by the weighted average number of outstanding common shares during the period. Diluted loss per share gives effect to all dilutive potential common shares outstanding during the period. Dilutive loss per share excludes all potential common shares if their effect is anti-dilutive. The Company has no potential dilutive instruments and accordingly basic loss and diluted loss per share are equal.

Fiscal Periods

The Company's fiscal year end is April 30.

Related Parties

Parties are considered to be related to the Company if the parties, directly or indirectly, through one or more intermediaries, control, are controlled by, or are under common control with the Company. Related parties also include principal owners of the Company, its management, members of the immediate families of principal owners of the Company and its management and other parties with which the Company may deal if one party controls or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests. The Company discloses all related party transactions. All transactions shall be recorded at fair value of the goods or services exchanged. Property purchased from a related party is recorded at the cost to the related party and any payment to or on behalf of the related party in excess of the cost is reflected as a distribution to related party.

Revenue Recognition

Pursuant to the guidance of ASC Topic 605, the Company recognizes revenue from product sales to its customers when: (1) title and risk of loss are transferred (in general, these conditions occur at either point of shipment or point of destination, depending on the terms of sale); (2) persuasive evidence of an arrangement exists; (3) the Company has no continuing obligations to the customer; and (4) collection of the related accounts receivable is reasonably assured.

Advance from Customers

The Company requires its customer to make payments prior to the products are shipped. Any payments received prior to the products are shipped to the customer’s point of destination are recorded as advance from customers.

Foreign Currency Translation.

The reporting currency of the Company is the U.S. dollar. The functional currency of the parent company is the U.S. dollar and the functional currency of the Company’s subsidiaries is the Hong Kong Dollar. For the subsidiaries, whose functional currencies are the Hong Kong Dollar, results of operations and cash flows are translated at average exchange rates during the period, assets and liabilities are translated at the unified exchange rate at the end of the period, and equity is translated at historical exchange rates. As a result, amounts relating to assets and liabilities reported on the statements of cash flows may not necessarily agree with the changes in the corresponding balances on the balance sheets. Translation adjustments resulting from the process of translating the local currency financial statements into U.S. dollars are included in determining comprehensive income. Assets and liabilities denominated in foreign currencies are translated into the functional currency at the exchange rates prevailing at the balance sheet date with any transaction gains and losses that arise from exchange rate fluctuations on transactions denominated in a currency other than the functional currency are included in the results of operations as incurred. Transactions denominated in foreign currencies are translated into the functional currency at the exchange rates prevailing on the transaction dates. During the years ended April 30, 2016, 2015 and 2014, the Company’s subsidiaries have no assets or liabilities and they did not have business activities. There was no cumulative translation adjustment and no effect of exchange rate changes on cash for the years ended April 30, 2016, 2015 and 2014.

Comprehensive Loss

Comprehensive loss is comprised of net loss and all changes to the statements of stockholders’ equity, except those due to investments by stockholders, changes in paid-in capital and distributions to stockholders. The Company did not have other comprehensive income (loss) for fiscal years ended April 30, 2016, 2015 or 2014.

Concentrations of Credit Risk

Financial instruments which potentially subject the Company to concentrations of credit risk consist principally of cash and marketable securities. We place our cash with high credit quality financial institutions in the United States. The Company has not experienced any losses in such accounts through April 30, 2016.

All of the Company’s sales are to one customer whose ability to pay is dependent upon the industry economics prevailing in these areas; however, the Company believes that the concentration of credit risk with respect to sales is limited due to the requirements for the customer to make payments prior to shipments. The Company also perform ongoing credit evaluations of its customer to help further reduce potential credit risk. However, if the Company is not able to increase the number of customers and loses its sole customer, there will be significant risks for the Company to continue to generate revenue.

Recent Accounting Pronouncements

In March 2016, the FASB issued ASU 2016-09, "Compensation - Stock Compensation (Topic 718): Improvements to Employee Share-Based Payment Accounting". Several aspects of the accounting for share-based payment award transactions are simplified, including: (a) income tax consequences; (b) classification of awards as either equity or liabilities; and (c) classification on the statement of cash flows. The amendments are effective for public companies for annual periods beginning after December 15, 2016, and interim periods within those annual periods. Early adoption is permitted for any interim or annual period. The Company is currently in the process of evaluating the impact of the adoption on its consolidated financial statements.

In July 2015, The FASB has issued Accounting Standards Update (ASU) No. 2015-11, Inventory (Topic 330): Simplifying the Measurement of Inventory. Topic 330, Inventory, currently requires an entity to measure inventory at the lower of cost or market. Market could be replacement cost, net realizable value, or net realizable value less an approximately normal profit margin. The amendments do not apply to inventory that is measured using last-in, first-out (LIFO) or the retail inventory method. The amendments apply to all other inventory, which includes inventory that is measured using first-in, first-out (FIFO) or average cost. An entity should measure in scope inventory at the lower of cost and net realizable value. Net realizable value is the estimated selling prices in the ordinary course of business, less reasonably predictable costs of completion, disposal, and transportation. Subsequent measurement is unchanged for inventory measured using LIFO or the retail inventory method. The amendments in this Update more closely align the measurement of inventory in GAAP with the measurement of inventory in International Financial Reporting Standards. For public business entities, the amendments are effective for fiscal years beginning after December 15, 2016, including interim periods within those fiscal years. For all other entities, the amendments are effective for fiscal years beginning after December 15, 2016, and interim periods within fiscal years beginning after December 15, 2017. The amendments should be applied prospectively with earlier application permitted as of the beginning of an interim or annual reporting period. The adoption of ASU 2015-11 is not expected to have a material impact on the Company’s consolidated financial statements.

In November 2015, the FASB issued new accounting guidance regarding the balance sheet classification of deferred income taxes. The primary objective of this accounting guidance is to classify all deferred income tax assets and liabilities as noncurrent in a classified statement of financial position. There was no material impact to results of operations as the result of adoption of the accounting pronouncement.

There are various other updates recently issued, most of which represented technical corrections to the accounting literature or application to specific industries and are not expected to a have a material impact on the Company's financial position, results of operations or cash flows.

Requirement for Funding

Our cash reserves are not sufficient to meet our obligations for the next twelve month period. As a result, we will need to seek additional funding in the near future. We currently do not have a specific plan of how we will obtain such funding; however, we anticipate that additional funding will be in the form of equity financing from the sale of shares of our common stock. We may also seek to obtain short-term loans from our directors or unrelated parties, although no such arrangements have been made. We do not have any arrangements in place for any future equity financing.

Material Commitments

As of April 30, 2016, we had no material commitments.

Purchase of Significant Equipment

We do not intend to purchase any significant equipment during the next twelve months.

Off Balance Sheet Arrangements

We have no off-balance sheet arrangements that have or are reasonably likely to have a current or future effect on our financial condition, changes in financial condition, revenues or expenses, results of operations, liquidity, capital expenditures or capital resources that is material to stockholders.

ITEM 7A. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

Exposure to credit, liquidity, interest rate and currency risks arises in the normal course of the Company’s business. The Company’s exposure to these risks and the financial risk management policies and practices used by the Company to manage these risks are described below.

various debt instruments.

Interest Rate Risk

We manage our interest rate risk by maintaining an investment portfolio of trading investments with high credit quality and relatively short average maturities. These instruments include, but are not limited to, money-market instruments, bank time deposits, and taxable and tax-advantaged variable rate and fixed rate obligations of corporations, municipalities, and national, state, and local government agencies, in accordance with an investment policy approved by our Board of Directors. These instruments are denominated in U.S. dollars. The fair market value of our investments as of April 30, 2016 was approximately $256,000. We also hold cash balances in accounts with a commercial bank in the United States. These cash balances represent operating balances only and are invested in short-term time deposits of the local bank.

Many of our investments carry a degree of interest rate risk. When interest rates fall, our income from investments in variable-rate securities declines. When interest rates rise, the fair market value of our investments in fixed-rate securities declines. In addition, our investments in equity securities are subject to stock market volatility. Due in part to these factors, our future investment income may fall short of expectations or we may suffer losses in principal if forced to sell securities, which have seen a decline in market value due to changes in interest rates. We attempt to mitigate risk by holding fixed-rate securities to maturity, but, if our liquidity needs force us to sell fixed-rate securities prior to maturity, we may experience a loss of principal. We believe that a 10% fluctuation in interest rates would not have a material effect on our financial condition or results of operations.

Currency Risk

We typically denominate our purchases and sales in U.S.dollars and our currency risk is minimal.

ITEM 8.

FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA

JOYMAIN INTERNATIONAL DEVELOPMENT GROUP INC.
INDEX TO CONSOLIDATED FINANCIAL STATEMENTS

CONTENTS

REPORTS OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM	F-2

CONSOLIDATED BALANCE SHEETS AS OF APRIL 30, 2016 AND 2015	F-4

CONSOLIDATED STATEMENTS OF OPERATIONS FOR THE YEARS ENDED APRIL 30, 2016, 2015 AND 2014	F-5

CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS’ EQUITY FOR THE YEARS ENDED APRIL30, 2016, 2015 AND 2014	F-6

CONSOLIDATED STATEMENTS OF CASH FLOWS FOR THE YEARS ENDED APRIL 30, 2016, 2015 AND 2014	F-7

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS	F-8 - F-16

F-1

REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

Shareholders and Directors
Joymain International Development Group Inc.

We have audited the accompanying consolidated balance sheets of Joymain International Development Group Inc. (the “Company”) as of April 30, 2016 and 2015 and the related consolidated statements of operations, changes in stockholders’ equity and cash flows for each of the three years in the period ended April 30, 2016. These consolidated financial statements are the responsibility of the Company’s management. Our responsibility is to express an opinion on these consolidated financial statements based on our audits.

We conducted our audits in accordance with the standards of the Public Company Accounting Oversight Board (United States). Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the consolidated financial statements are free of material misstatement. An audit includes examining, on a test basis, evidence supporting the amounts and disclosures in the consolidated financial statements. An audit also includes assessing the accounting principles used and significant estimates made by management, as well as evaluating the overall financial statement presentation. We believe that our audits provide a reasonable basis for our opinion.

In our opinion, the consolidated financial statements referred to above present fairly, in all material respects, the consolidated financial position of the Company as of April 30, 2016 and 2015 and the consolidated results of its operations and its cash flows for each of the three years in the period ended April 30, 2016, in conformity with accounting principles generally accepted in the United States of America.

We also have audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States), the Company’s internal control over financial reporting as of April 30, 2016, based on criteria established in Internal Control - Integrated Framework (2013) issued by the Committee of Sponsoring Organizations of the Treadway Commission (COSO) and our report dated August 19, 2016 expressed an adverse opinion on the Company’s internal control over financial reporting.

The accompanying consolidated financial statements have been prepared assuming that the Company will continue as a going concern. As discussed in Note 2 to the consolidated financial statements, the Company has incurred significant losses since inception. This condition and among others raise substantial doubt about the Company's ability to continue as a going concern. Management's plans, with respect to these matters are also described in Note 2 to the consolidated financial statements. The consolidated financial statements do not include any adjustments that might result should the Company be unable to continue as a going concern.

/s/ RBSM LLP

New York, NY
August 19, 2016

F-2

REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

Board of Directors and Shareholders
Joymain International Development Group Inc.

We have audited the internal control over financial reporting of Joymain International Development Group Inc. (the “Company”) as of April 30, 2016, based on the criteria established in Internal Control - Integrated Framework (2013) issued by the Committee of Sponsoring Organizations of the Treadway Commission (COSO). The Company’s management is responsible for maintaining effective internal control over financial reporting and for its assessment of the effectiveness of internal control over financial reporting, included in the accompanying Management’s Annual Report on Internal Control over Financial Reporting, appearing in Item 9A. Our responsibility is to express an opinion on the Company’s internal control over financial reporting based on our audit.

We conducted our audit in accordance with the standards of the Public Company Accounting Oversight Board (United States). Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the effective internal control over financial reporting was maintained in all material aspects. Our audit included obtaining an understanding of internal control over financial reporting, assessing the risk that a material weakness exists, and testing and evaluating the design and operating effectiveness of internal control based on the assessed risk. Our audit also included performing such other procedures as we considered necessary in the circumstances. We believe that our audit provides a reasonable basis for our opinion.

A company’s internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles. A company’s internal control over financial reporting includes those policies and procedures that (1) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the Company; (2) provide reasonable assurance that the transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that receipts and expenditures of the company are being made only in accordance with authorizations of management and directors of the Company; and (3) provide reasonable assurance regarding prevention of timely detection of unauthorized acquisition, use, or disposition of the company’s assets that could have a material effect on the financial statements.

Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risks that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.

A material weakness is a control deficiency, or combination of deficiencies, in internal control over financial reporting, such that there is a reasonable possibility that a material misstatement of the Company’s annual or interim financial statements will not be prevented or detected on a timely basis. The following material weaknesses have been identified and included in management’s assessment. These material weaknesses are consisting of 1) lack of adequate segregation of duties among accounting, reporting, business and operation functions due to its business size and limited staff, 2) due to the need for more enhance and formalized documentation and procedures regarding the financial closing, reporting and review process to ensure that the application of the Company’s accounting policies and the presentation of disclosures in the Company’s financial statements is adequate; and 3) did not effectively and timely evaluate the impact of the Company’s unaffiliated aggregated market value being in excess of $75 million (reported level of $576 million) as of October 31, 2015 until during the second half of July 2016. As a result, management did not initiate their internal control related documentation, testing and assessment until upon their determination during July 2016, which led to not timely filing the Company’s fiscal year ended April 30, 2016 Annual Report on the SEC Form 10-K. These material weaknesses were considered in determining the nature, timing, and extent of audit tests applied in our audit of the April 30, 2016’s consolidated financial statements, and this report does not affect our report dated August 19, 2016 on those consolidated financial statements.

In our opinion, because of the effect of the material weakness described above on the achievement of the objectives of the control criteria, Joymain International Development Group Inc. has not maintained effective internal control over financial reporting as of April 30, 2016, based on criteria established in internal control - Integrated Framework (2013) issued by the Committee of Sponsoring Organizations of the Treadway Commission (COSO).

We also have audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States), the consolidated balance sheets of Joymain International Development Group Inc. as of April 30, 2016 and 2015, and the related consolidated statements of operations, changes in stockholders’ equity, and cash flows for each of the three years in the period ended April 30, 2016 and our report dated August 19, 2016 expressed an unqualified opinion with an explanatory paragraph on those consolidated financial statements.

/s/ RBSM LLP

New York, NY
August 19, 2016

F-3

JOYMAIN INTERNATIONAL DEVELOPMENT GROUP, INC.
CONSOLIDATED BALANCE SHEETS

		April 30			April 30
		2016			2015


ASSETS
CURRENT ASSETS:
Cash	$	1,116,966		$	878,839
Advance to suppliers		62,736			1,293,030
Marketable securities		255,824			359,857

TOTAL CURRENT ASSETS		1,435,526			2,531,726

PROPERTY AND EQUIPMENT - Net		1,155			1,555

TOTAL ASSETS	$	1,436,681		$	2,533,281


LIABILITIES AND STOCKHOLDERS' EQUITY

CURRENT LIABILITIES:
Accounts payable	$	5,299		$	24,726
Due to related parties		235			3,529
Advance from customer		428,781			1,423,031
Other payables		51,817			23,749

TOTAL CURRENT LIABILITIES		486,132			1,475,035

STOCKHOLDERS' EQUITY:
Common stock,1,500,000,000 shares authorized, par value $0.001, 1,120,343,373 shares issued and outstanding at April 30, 2016 and 2015, respectively		1,120,343			1,120,343
Additional paid-in capital		14,436,858			14,436,858
Accumulated deficit		(14,606,652	)		(14,498,955	)

TOTAL STOCKHOLDERS' EQUITY		950,549			1,058,246


TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY	$	1,436,681		$	2,533,281

See accompanying notes to consolidated financial statements

F-4

JOYMAIN INTERNATIONAL DEVELOPMENT GROUP, INC.
CONSOLIDATED STATEMENTS OF OPERATIONS

		For the Years Ended
		April 30
		2016			2015			2014

REVENUE	$	2,765,801		$	1,506,516		$	-

COST OF REVENUE		2,548,037			1,377,855			-

GROSS PROFIT		217,764			128,661			-

OPERATING EXPENSES
General and administrative		(326,572	)		(418,221	)		(167,465	)
Business development expenses		-			(13,118,270	)		-
Total Operating Expenses		(326,572	)		(13,536,491	)		(167,465	)

LOSS FROM OPERATIONS		(108,808	)		(13,407,830	)		(167,465	)

OTHER INCOME
Interest income		955			1,532			1,806
Other income		156			12,364			-
Total other income		1,111			13,896			1,806

LOSS BEFORE PROVISION FOR INCOME TAXES		(107,697	)		(13,393,934	)		(165,659	)

PROVISION FOR INCOME TAXES		-			-

NET LOSS	$	(107,697	)	$	(13,393,934	)	$	(165,659	)

BASIC AND DILUTED:
Loss per common share	$	a		$	(0.01	)	$	a

WEIGHTED AVERAGE NUMBER OF
COMMON SHARES		1,120,343,373			996,609,101			954,720,959

a= Less than ($0.01) per share

See accompanying notes to consolidated financial statements

F-5

JOYMAIN INTERNATIONAL DEVELOPMENT GROUP, INC.
CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY
For the Years Ended April 30, 2016, 2015 and 2014

	Common Stock										Total
	Number of				Additional			Accumulated			Stockholders'
	Shares		Amount		Paid-in Capital			Deficit			Equity
Balance, April 30, 2013	904,500,000	$	904,500	$	3,785		$	(939,362	)	$	(31,077	)

Common shares sold at $0.03 per share	49,330,000		49,330		1,430,570			-			1,479,900

Common shares offering costs	-		-		(31,104	)		-			(31,104	)

Net loss	-		-		-			(165,659	)		(165,659	)

Balance, April 30, 2014	953,830,000	$	953,830	$	1,403,251		$	(1,105,021	)	$	1,252,060

Shares issued for consulting expenses at $0.03 per share	2,390,000		2,390		69,310			-			71,700

Common shares sold at $0.07per share	145,000		145		10,005			-			10,150

Shares issued for bus develop. expenses at $0.08 per share	163,978,373		163,978		12,954,292						13,118,270

Net loss	-		-		-			(13,393,934	)		(13,393,934	)

Balance, April 30, 2015	1,120,343,373	$	1,120,343	$	14,436,858		$	(14,498,955	)	$	1,058,246

Net loss	-		-		-			(107,697	)		(107,697	)

Balance, April 30, 2016	1,120,343,373	$	1,120,343	$	14,436,858		$	(14,606,652	)	$	950,549

See accompanying notes to consolidated financial statements

F-6

JOYMAIN INTERNATIONAL DEVELOPMENT GROUP, INC.
CONSOLIDATED STATEMENTS OF CASH FLOWS

		For the Years Ended Ended
					April 30,
		2016			2015			2014
OPERATING ACTIVITIES:
Net loss	$	(107,697	)	$	(13,393,934	)	$	(165,659	)
Adjustments to reconcile net loss to net cash provided by (used in) operating activities
Depreciation and amortization		400			400			97
Stock issued for consulting fees		-			71,700			-
Stock issued for business development expenses		-			13,118,270			-
Expenses paid directly by related parties		-			8,290			-
Unrealized loss (gain) on marketable securities, net of investment management fees		3,624			(9,857	)		-
Changes in operating assets and liabilities
Prepaid expenses		-			900			1,045
Advance to suppliers		1,230,294			(1,293,030	)		-
Accounts payable		(19,427	)		12,038			6,779
Advance from customers		(994,250	)		1,423,031			-
Other payable		28,068			23,749			-

NET CASH PROVIDED BY (USED IN) OPERATING ACTIVITIES		141,012			(38,443	)		(157,738	)

INVESTING ACTIVITIES:
Purchase of property and equipment		-			-			(2,052	)
Purchase of marketable securities		-			(350,000	)		-
Proceed from sell of marketable securities		100,409			-			-

NET CASH PROVIDED BY (USED IN) INVESTING ACTIVITIES		100,409			(350,000	)		(2,052	)

FINANCING ACTIVITIES:
Proceeds from issuance of common stock		-			10,150			1,479,900
Payments of common stock offering costs		-			-			(31,104	)
Repayments to related parties		(3,294	)		(44,676	)		(48,040	)
Proceeds from related parties		-			60			60,782

NET CASH (USED IN) PROVIDED BY FINANCING ACTIVITIES		(3,294	)		(34,466	)		1,461,538

Net Increase (Decrease) in Cash		238,127			(422,909	)		1,301,748
Cash, Beginning of Period		878,839			1,301,748			-

CASH, END OF PERIOD	$	1,116,966		$	878,839		$	1,301,748

SUPPLEMENTAL DISCLOSURES OF CASH FLOW INFORMATION
Cash paid during the period for:
Interest		-			-			-

Income Taxes		-			-			-

See accompanying notes to consolidated financial statements

F-7

JOYMAIN INTERNATIONAL DEVELOPMENT GROUP INC.

Notes to Consolidated Financial Statements
April 30, 2016 and 2015

NOTE 1. ORGANIZATION AND BUSINESS OPERATIONS

Joymain International Development Group Inc. (f/k/a Advento, Inc.) (“the Company”, “we”, “us”, “our”) was incorporated under the laws of the State of Nevada, U.S. on August 4, 2010 under the name Advento, Inc. The Company develops, sources, markets and distributes healthcare related consumer products in the global market On March 12, 2013, Mr. Xijian Zhou acquired an aggregate of 750,000,000 shares of the Company’s common stock, representing 82.92% of our issued and outstanding shares as of March 12, 2013. Effective March 12, 2013, (a) Mr. Liang Wei Wang resigned as the Company’s president, secretary, treasurer, and director of the Company; (b) Mr. Suqun Lin, was appointed as the Company’s sole director, president, secretary and treasurer. Effective March 28, 2013, the Nevada Secretary of State accepted for filing of a Certificate of Amendment to the Company’s Articles of Incorporation to change the Company’s name from Advento, Inc. to Joymain International Development Group Inc. and to increase its authorized capital from 75,000,000 to 1,500,000,000 shares of common stock, par value of $0.001. These amendments became effective on April 10, 2013 upon approval from the Financial Industry Regulatory Authority (“FINRA”). Also effective April 10, 2013, pursuant to a 300 new for one (1) old forward split, the Company’s issued and outstanding shares of common stock increased from 3,015,000 to 904,500,000 shares, par value of $0.001. Information regarding shares of common stock (except par value per share), discount on stock issued, and net (loss) income per common share for all periods presented reflects the three hundred-for-one forward split of the Company’s common stock.

In connection with the change of control, the Company changed its business operation plan to develop, source, market and distribute healthcare related consumer products in the global market and possibly acquire an existing target company or business in the related field which operates in the United States.

In May 2014, The Company acquired a HK trading company, Dao Sheng Trading Limited (“Dao Sheng”) for HK$10,000. Dao Sheng was incorporated in December 2013 and had no assets or liabilities at the time of the acquisition. The Company also set up Joymain International Intellectual Property Limited in Hong Kong in May 2014. The Company considers Hong Kong as an ideal location to connect to all Asian markets and it provides a comprehensive and advanced legal system for trading and intellectual property protection.

NOTE 2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

Basis of Presentation.

The consolidated financial statements of the Company have been prepared in accordance with generally accepted accounting principles in the United States of America and are presented in US dollars. The Company’ s consolidated financial statements included the financial statements of its wholly-owned subsidiaries, Dao Sheng and Joymain International Intellectual Property Limited. All significant intercompany accounts and transactions have been eliminated in consolidation.

Going Concern

F-8

The Company expects to depend on outside capital for its future business developments. Such outside capital will include proceeds from the issuance of equity securities and may include commercial borrowing. There can be no assurance that capital will be available as necessary to meet these development costs or, if the capital is available, that it will be on terms acceptable to the Company. The Company has a registration statement on Form S-1, effective on August 1, 2014, pursuant to which the Company planned to raise up to $12 million in equity. The registration statement expired on November 28, 2014 and the Company raised $10,150 in the offering.

Cash and Cash Equivalents

Use of Estimates and Assumptions

Inventories

F-9

Advance to Suppliers

The Company periodically makes advances to vendors for purchases of products for resale, and records these purchases as advance to suppliers.

Fair Value of Financial Instruments

The following table sets forth by level within the fair value hierarchy of the Company’s financial assets that were accounted for at fair value on a recurring basis as of April 30, 2016 and 2015:

				April 30, 2016								April 30, 2015
		Level 1		Level 2		Level 3		Total		Level 1		Level 2		Level 3		Total

Marketable securities	$	255,824	$	—	$	—	$	255,824	$	359,857	$	—	$	—	$	359,857
Total assets at fair value	$	255,824	$	—	$	—	$	255,824	$	359,857	$	—	$	—	$	359,857

Stock-based Compensation

To date, the Company has not adopted a stock option plan and has not granted any stock options.

F-10

Income Taxes

Basic and Diluted Loss Per Share

Fiscal Periods

The Company's fiscal year end is April 30.

Related Parties

Revenue Recognition

F-11

Advance from Customers

Foreign Currency Translation.

The reporting currency of the Company is the U.S. dollar. The functional currency of the parent company is the U.S. dollar and the functional currency of the Company’s subsidiaries is the Hong Kong Dollar. For the subsidiaries, whose functional currencies are the Hong Kong Dollar, results of operations and cash flows are translated at average exchange rates during the period, assets and liabilities are translated at the unified exchange rate at the end of the period, and equity is translated at historical exchange rates. As a result, amounts relating to assets and liabilities reported on the statements of cash flows may not necessarily agree with the changes in the corresponding balances on the balance sheets. Translation adjustments resulting from the process of translating the local currency financial statements into U.S. dollars are included in determining comprehensive income. Assets and liabilities denominated in foreign currencies are translated into the functional currency at the exchange rates prevailing at the balance sheet date with any transaction gains and losses that arise from exchange rate fluctuations on transactions denominated in a currency other than the functional currency are included in the results of operations as incurred. Transactions denominated in foreign currencies are translated into the functional currency at the exchange rates prevailing on the transaction dates. During the year ended April 30, 2016, 2015, and 2014, the Company’s subsidiaries have no assets or liabilities and they did not have any business activities. There was no cumulative translation adjustment and no effect of exchange rate changes on cash for the year ended April 30, 2015 and 2016.

Comprehensive Loss

Comprehensive loss is comprised of net loss and all changes to the statements of stockholders’ equity, except those due to investments by stockholders, changes in paid-in capital and distributions to stockholders. The Company did not have any other comprehensive gain (loss) for fiscal years 2016, 2015 and 2014.

Concentration of Credit Risk

F-12

Recent Accounting Pronouncements

NOTE 3. MARKETABLE SECURITIES.

Marketable securities consist of certificate of deposits and mutual funds for which fair values were based on quoted prices in active markets and were therefore classified within Level 1 of the fair value hierarchy. The following table is a summary of marketable securities recorded in the Company’s Consolidated Balance Sheets:

		April 30, 2016		April 30, 2015
Certificate of deposits	$	-	$	100,409
Mutual funds		255,824		259,448
Total	$	255,824	$	359,857

The Company sold the certificate of deposits upon its maturity and transferred the proceed / fund to its operating bank account for working capital purposes during fiscal 2016.

NOTE 4. ADVANCE TO SUPPLIERS AND ADVANCE FROM CUSTOMERS

The Company makes advance payments to suppliers for goods ordered but yet to be delivered to our customer as it has a drop ship arrangement between its suppliers and customer. The Company receives advance payments from customers for goods ordered but yet to be shipped and/or shipped to its customers’ point of destination. Advanced payments to suppliers as of April 30, 2016 and 2015 were $62,736 and $1,293,000, respectively. Advanced payments from customers as of April 30, 2016 and 2015 were $428,781 and $1,423,031, respectively.

On June 25, 2014, the Company entered into a distribution agreement with Right Fortune International Limited (“Right Fortune”) to obtain the exclusive distribution right of Yolexury and Yolexury Travel Pack, a health juice product which increases energy and stamina, helps to maintain healthy cardio vascular function and promotes healthy digestive system. The term of exclusivity will be automatically renewed annually if the Company meets the annual Yolexury Minimum Order Quantities (the “Minimum Order”). The annual Minimum Order for calendar year 2015 is 400,000 bottles of 750ml Yolexury, which the Company has fulfilled as of December 31, 2015. The Company works with its vendor and customer to arrange the drop shipments for its inventories and the inventories are shipped directly to the ports designated by the Company’s customer from the manufacture factory without going through the Company’s warehouse to conserve shipping costs.

F-13

NOTE 5. RELATED PARTY TRANSACTIONS

For the years ended April 30, 2016, 2015 and 2014, the Company’s majority shareholder advanced the Company for its working capital of $0, $60 and $60,782, respectively. For the years ended April 30, 2016, the Company repaid its major shareholder of $3,294, $44,676 and $48,040, respectively. In addition, the Company’s majority shareholder paid certain payroll expense and other general expenses on behalf of the Company for total amount of $0, $8,290 and $0 for the years ended April 30, 2016, 2015 and 2014, respectively. The advances are non-interest bearing, due upon demand and unsecured. At April 30, 2016 and 2015, the Company’s due to related parties amounted to $235 and $3,529, respectively.

NOTE 6. OTHER PAYABLES

Other payables consist of accrued salary and related accrued expenses. The amounts are expected to be repaid in the form of cash. At April 30, 2016 and 2015, the Company’s other payable amounted to $51,817 and $23,749, respectively.

NOTE 7. STOCKHOLDERS’ EQUITY (DEFICIT)

The Company has authorized 1,500,000,000 shares of common stock, par value $0.001 per share. On April 28, 2011, the Company issued 750,000,000 shares of common stock at a price of $0.000003 per share for total cash proceeds of $2,500. In March and April, 2012, the Company issued 154,500,000 shares of common stock at a price of $0.00016 per share for total cash proceeds of $25,750. On July 30, 2014, the Company issued a total of 2,390,000 shares of common stock to a consultant. The shares were valued at $0.03 per share, the fair market value on the date of issuance. During the year ended April 30, 2015, the Company recorded stock-based compensation of $71,700.

In August 2014, the Company sold a total of 110,000 shares of common stock at a price of $0.07 per share to two investors. The shares were sold pursuant to the Company’s registration statement on Form S-1, file number 333-197508, effective on August 1, 2014. The Company did not engage a placement agent with respect to the sale. The net proceeds received by the Company from the sale of the shares were $7,700.

In September 2014, the Company sold a total of 35,000 shares of common stock at a price of $0.07 per share to two investors. The shares were sold pursuant to the Company’s registration statement on Form S-1, file number 333-197508, effective on August 1, 2014. The Company did not engage a placement agent with respect to the sale. The net proceeds received by the Company from the sale of the shares were $2,450. The Form S-1, file number 333-197508, expired on November 28, 2014.

In January, 2015, the Company issued a total of 163,978,373 shares of common stock to its 34 distribution and development partners. The shares were valued at $0.08 per share, the fair market value on the date of issuance. The Company recorded stock-based business development expenses of $13,118,270 for the year ended April 30, 2015.

On February 11, 2015, the Company filed a registration statement on Form S-1 (the “Form S-1”) related to the resale of up to 51,720,000 shares of the Company’s common stock (the “Common Stock”) including 49,330,000 shares of Common Stock issued at a price of $0.03 per share for a total gross cash proceeds of $1,479,900 in a private placement transaction closed on July 19, 2014 and 2,390,000 shares of Common Stock issued pursuant to a consulting agreement date May 10, 2014 between the Company and LP Funding LLC. The selling stockholders may sell common stock from time to time in the principal market on which the stock is traded at the prevailing market price, at prices related to such prevailing market price, in negotiated transactions or a combination of such methods of sale. We will not receive any proceeds from the sales by the selling stockholders. The Form S-1 was declared effective on April 24, 2015.

On June 15, 2015, trading in our Common Stock was temporarily suspended by the Securities and Exchange Commission (the “Commission”) due to recent unexplained market activity. As a result, trading in our Common Stock was suspended for the period from 9:30 am EDT on June 15, 2015, through 11:50 pm EDT on June 26, 2015.

We had 1,120,343,373 shares of common stock issued and outstanding as of April 30, 2016 and 2015.

NOTE 8. INCOME TAXES

We account for income taxes under ASC 740, “Expenses - Income Taxes” . ASC 740 requires the recognition of deferred tax assets and liabilities for both the expected impact of differences between the financial statements and the tax basis of assets and liabilities, and for the expected future tax benefit to be derived from tax losses and tax credit carry forwards. ASC 740 additionally requires the establishment of a valuation allowance to reflect the likelihood of realization of deferred tax assets.

F-14

The income tax provision (benefit) for the years ended April 30, 2016, 2015 and 2014 consists of the following:

		For the Years Ended April 30,
		2016			2015			2014
Expected income tax expense (benefit) at the statutory rate of 34%	$	(37,000	)	$	(4,454,000	)	$	(57,000	)

Tax effect of expenses (benefit) that are not deductible for income tax purposes (net of other amounts deductible for tax purposes)		-			-			-

Change in valuation allowance		37,000			4,454,000			57,000
Provision for income taxes	$	-		$	-		$	-

The Company has a net operating loss (“NOL”) carryforward for U.S. income tax purposes aggregating approximately $13,714,000 at April 30, 2016 expiring through the year 2035, subject to the Internal Revenue Code Section 382, which places a limitation on the amount of taxable income that can be offset by net operating losses after a change in ownership. The Company has no Hong Kong NOL for its inactive subsidiaries in Hong Kong as of April 30, 2016.

Deferred income taxes reflect the net tax effects of temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and the amounts used for income tax purposes. Included in the deferred tax asset is the aforementioned NOL and the tax benefit associated with the issuance of stock-based compensation. The realization of the deferred tax assets is dependent on future taxable income, in addition to the exercise of stock options; we are not able to predict if such future taxable income will be more likely than not sufficient to utilize the benefit. As such, we do not believe the benefit is more likely than not to be realized and we recognize a full valuation allowance for those deferred tax assets. Our deferred tax assets as of April 30, 2016 and 2015 are as follows:

		As of April 30,
		2016			2015
Deferred income tax asset:
Net operating loss carryforwards	$	4,663,000		$	4,626,000
Valuation allowance		(4,663,000	)		(4,626,000	)
Deferred income taxes	$	-		$	-

The increases in the valuation allowance at April 30, 2016 and 2015 from their immediate prior year-end was $37,000 and $4,454,000, respectively.

The Company has filed its U.S. tax returns through April 30, 2015.

F-15

Our subsidiaries in Hong Kong have no business activities since inception and are governed by the Income Tax Law of the Hong Kong Special Administrative Region (“HK SAR”) and local income tax laws (the HK SAR Income Tax Law”). Pursuant to the HK SAR Income Tax Law, our Hong Kong subsidiaries are subject to tax at a maximum statutory rate of 17% (inclusive of state and local income taxes) if in operations.

The provisions of ASC 740 require companies to recognize in their financial statements the impact of a tax position if that position is more likely than not to be sustained upon audit, based upon the technical merits of the position. ASC 740 prescribes a recognition threshold and measurement attribute for the financial statement recognition and measurement of a tax position taken or expected to be taken on a tax return. ASC 740 also provides guidance on derecognition, classification, interest and penalties, accounting in interim periods and disclosure.

Management does not believe that the Company has any material uncertain tax positions requiring recognition or measurement in accordance with the provisions of ASC 740. Accordingly, the adoption of these provisions of ASC 740 did not have a material effect on the Company’s financial statements. The Company’s policy is to record interest and penalties on uncertain tax positions, if any, as income tax expense.

All tax years for the Company remain subject to future examinations by the applicable taxing authorities.

NOTE 9. COMMITMENTS AND CONTINGENCIES

In May 2016, the Company received certain informal inquiry from the Commission regarding trading activity in our common stock and the Company is currently in the process of responding to such inquiry. The inquiry requires that the Company provide certain categories of documents to the Commission. The Commission indicated in its inquiry that it should not be construed as an indication that any violation of any federal securities laws has occurred or as a reflection upon the merits of any person, company, or securities involved. The inquiry is a confidential non-public fact finding request. It is not possible at this time to predict the outcome of the inquiries, including whether or when any proceedings might be initiated, when these matters may be resolved or what, if any, penalties or other remedies may be imposed. The Company has been, and intend to continue, voluntarily cooperating fully with the SEC. The scope and outcome of this matter cannot be determined at this time. The Company has expended significant resources to the Internal Investigation (see NOTE 7) and responding to the Commission’s inquiry. Failure to resolve such matters favorably could harm tradability of our common stock and our reputation significantly and could result in a loss of your investment in our stock.

NOTE 10. SUBSEQUENT EVENTS

The Company has evaluated subsequent events through the date of the consolidated financial statements were issued and up to the time of filing of the consolidated financial statements with the Securities and Exchange Commission. There are no events that have occurred subsequent to the balance sheet date and through the date of the filing date of this report that would require adjustment to, or disclosure in the accompanying consolidated financial statements, except as disclosed on Note 9, “Commitments and Contingencies”.

F-16

ITEM 9.

CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON ACCOUNTING AND FINANCIAL DISCLOSURE

None

ITEM 9A. CONTROLS AND PROCEDURES

Conclusion Regarding the Effectiveness of Disclosure Controls and Procedures

Under the supervision and with the participation of our management, including our Chief Executive officer and Chief Financial officer, we conducted an evaluation of our disclosure controls and procedures, as such term is defined under Rule 13a-15(e) promulgated under the Securities Exchange Act of 1934, as amended (the “Exchange Act”). Controls and other procedures that are designed to provide reasonable assurance that the information that we are required to disclose in the reports that we file or submit under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms, and that such information is accumulated and communicated to our management, including our Chief Executive Officer and Chief Financial Officer, as appropriate to allow timely decisions regarding required disclosure.

Based on this evaluation, our Chief Executive Officer and Chief Financial Officer concluded that our disclosure controls and procedures were not effective at the reasonable assurance level as of April 30, 2016, due to the material weakness in internal control described below.

We performed additional analyses and other procedures to ensure that our consolidated financial statements included in this Annual Report were prepared in accordance with US GAAP. These measures included, among other things, expansion of our year-end closing procedures, including the consolidation process, and dedication of significant internal resources and external consultants to scrutinize account analyses and reconciliations at a detailed level. As a result, we concluded that the consolidated financial statements included in this Annual Report present fairly, in all material respects, our financial position, results of operations and cash flows for the periods presented in conformity with US GAAP.

Management Report on Internal Control Over Financial Reporting

Our management, under the supervision of our Chief Executive Officer and Chief Financial Officer, is responsible for establishing and maintaining adequate internal control over financial reporting to provide reasonable assurance regarding the reliability of our financial reporting and the preparation of consolidated financial statements for external purposes in accordance with U.S. generally accepted accounting principles. Internal control over financial reporting includes but not limits to those policies and procedures that (i) pertain to the maintenance of records that in reasonable detail accurately and fairly reflect the transactions and dispositions of the assets of the Company; (ii) provide reasonable assurance that transactions are recorded as necessary to permit preparation of consolidated financial statements in accordance with U.S. generally accepted accounting principles, and that receipts and expenditures of the Company are being made only in accordance with authorizations of management and directors of the Company; and (iii) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use, or disposition of the Company’s assets that could have a material effect on the consolidated financial statements.

Any system of internal control, no matter how well designed, has inherent limitations, including the possibility that a control can be circumvented or overridden and misstatements due to error or fraud may occur and not be detected in a timely manner. Also, because of changes in conditions, internal control effectiveness may vary over time. Accordingly, even an effective system of internal control will provide only reasonable assurance with respect to consolidated financial statement preparation. In addition, the design of any system of controls is based in part on certain assumptions about the likelihood of future events, and there can be no assurance that any design will succeed in achieving its stated goals under all potential future conditions. Over time, controls may become inadequate because of changes in conditions or deterioration in the degree of compliance with policies or procedures. Therefore, any current evaluation of controls cannot and should not be projected to future periods.

Management assessed our internal control over financial reporting as of the year ended April 30, 2016. In making this assessment, management used the criteria set forth by the Committee of Sponsoring Organizations of the Treadway Commission (COSO) in 2013 Internal Control-Integrated Framework. The 2013 COSO framework summarizes each of the components of a company’s internal control system, including (i) the control environment, (ii) risk assessment, (iii) control activities, (iv) information and communication, and (v) monitoring.

Based on management’s assessment using the 2013 COSO framework, management identified material weaknesses over financial reporting consisting of 1) lack of adequate segregation of duties among accounting, reporting, business and operation functions due to its business size and limited staff, 2) due to the need for more enhance and formalized documentation and procedures regarding the financial closing, reporting and review process to ensure that the application of the Company’s accounting policies and the presentation of disclosures in the Company’s financial statements is adequate; and 3) did not effectively and timely evaluate the impact of the Company’s unaffiliated aggregated market value being in excess of $75 million (reported level of $576 million) as of October 31, 2015 until during the second half of July 2016. As a result, management did not initiate their internal control related documentation, testing and assessment until upon their determination during July 2016, which led to not timely filing the Company’s fiscal year ended April 30, 2016 Annual Reprt on the SEC Form 10-K.. As a result, management has concluded that the Company’s internal control over financial reporting was not effective as of April 30, 2016 to provide reasonable assurance regarding the reliability of financial reporting and the preparation of consolidated financial statements for external reporting purposes in accordance with U.S. generally accepted accounting principles.

A material weakness (within the meaning of PCAOB Auditing Standard No. 5) is a deficiency, or a combination of deficiencies, in internal control over financial reporting, such that there is a reasonable possibility that a material misstatement of our annual or interim financial statements will not be prevented or detected on a timely basis. A significant deficiency is a deficiency, or a combination of deficiencies, in internal control over financial reporting that is less severe than a material weakness, yet important enough to merit attention by those responsible for oversight of the company’s financial reporting.

In light of these material weaknesses, management performed additional analyses and procedures in order to conclude that our consolidated financial statements included in this Annual Report on Form 10-K were fairly stated in accordance with GAAP. Accordingly, management believes that despite our material weaknesses and significant deficiencies identified, our consolidated financial statements for the year ended April 30, 2016 are fairly stated, in all material respects, in accordance with GAAP.

Due to our size and nature, segregation of all conflicting duties may not always be possible and may not be economically feasible. As a result, we have not been able to take steps to improve our internal controls over financial reporting during the year ended April 30, 2016. However, to the extent possible, we continue to evaluate the effectiveness of internal controls and procedures on an on-going basis. Once our cash flows from operations improve to a level where we are able to hire additional personnel in financial reporting, we plan to improve our internal controls and procedures by hiring an experienced controller and building an internal accounting team with sufficient in-house expertise in US GAAP reporting. However, due to the limited cash flow we are currently having, we can not assure you when we will be able to implement those remediation methods.

Remediation of Material Weakness

Our management has proposed to under taking the following proposed remediation plan and actions:

	a.	Management will review the current organization structure and job assignments to minimize the conflict of duties assigned to the same staff. In addition, management will implement compensating controls to mitigate the risks raised from lack of segregation of duties in key accounting and reporting functions.
	b.	A formal policy and procedures for identification, authorization, review and approval of accounting transactions as well as appropriate application of accounting policies and presentation of disclosures of the Company’s financial statements will be implemented during the first half of our fiscal year ending April 30, 2017.

Attestation Report of Independent Registered Republic Accounting Firm

Our independent registered public accounting firm, RBSM LLP, has issued an audit report with respect to our internal control over financial reporting, which appears in this Part II, Item 8 of this Annual Report on Form 10-K.

Changes in Internal Control over Financial Reporting

There has been no change in our internal control over financial reporting identified in connection with our evaluation we conducted of the effectiveness of our internal control over financial reporting as of April 30, 2016, that occurred during our fourth fiscal quarter that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.

ITEM 9B. OTHER INFORMATION

None.

PART III

ITEM 10.

DIRECTORS, OFFICERS AND CORPORATE GOVERNANCE

DIRECTORS AND EXECUTIVE OFFICERS

All directors of our company hold office until the next annual meeting of the security holders or until their successors have been elected and qualified. The officers of our company are appointed by our board of directors and hold office until their death, resignation or removal from office. We do not have written employment contracts or directorship contracts with our officers and directors. .

The name and position of our present officers and directors are set forth below:

Name	Age	Position	Date First Elected or Appointed
Suqun Lin	36	President, Chief Executive Officer, Secretary and Director	March 12, 2013

Chengjie He	31	Chief Financial Officer and Treasure	April 1, 2014

Jian Shao	49	Chief Business Development Officer	April 1, 2014

BIOGRAPHICAL INFORMATION AND BACKGROUND OF OFFICER AND DIRECTOR

Suqun Lin - President, Secretary, Chief Executive Officer and Director

Suqun Lin was appointed as our president, secretary, treasurer and director on March 12, 2013. Since September 2010, Mr. Lin has been the senior operating officer, China District, of Nanjing Joymain a company that specializes in research and development, production and marking of high-tech health care products and our majority shareholder Mr. Xijian Zhou is a consultant and involved in making business decisions of that entity. As senior operating officer, Mr. Lin is responsible for managing the operations, logistics, customer services, production and procurement departments in the People’s Republic of China. Mr. Lin first joined Naijing Joymain as an administration manager in May 2009 and managed the human resources and office administration of the company. Mr. Lin was promoted to director of the president’s office in December 2009 and further promoted to senior operating officer, China District in December 2010.

From April 2008 to April 2009, Mr. Lin was the Shenzhen branch manager of Shenzhen Yuelang Science and Technology Development Co., Ltd., wherein he managed the business development and public relation affairs in the Shenzhen area. Mr. Lin graduated from Fuzhou University with a Bachelor’s degree in Mechanical Design and Automation.

Chengjie He - Chief Financial Officer and Treasurer

Mr. He has been the Executive Assistant to CEO of Nanjing Joymainan since March 2013. As Executive Assistant to CEO, Mr. He serves as liaison to the Board of Directors and the senior management team of Nanjing Joymain and completes a board variety of administrative tasks for Nanjing Joymain. He also manages special overseas investment projects for Nanjing Joymain and monitors various financial reports. From February 2011 to January 2013, Mr. He was the Executive Assistant to the General Manager of United Industry (Asia) Co. Ltd. (“United Industry”), a global household appliance parts supply company. He was responsible for follow-up activities related to United Industry’s investment projects in Jiangsu, China area and participated in the project negotiations and relationship management with the local government. He also monitored four subsidiaries’ cash flows and administrative activities for United Industry. From February 2010 to January 2011, Mr. He was Assistant to Chairman of Nanjing Gianda Construction Investment Group, a construction and real estate investment company, responsible for planning and coordinating the Chairman’s daily schedule. He was also assigned to co-manage the financial department and co-monitor cash flow on various construction projects with the CFO. From June 2006 to January 2008, Mr. He was the Import and Export assistant at Taizhou Kim-top Electromechanical Ltd. responsible for customer communication and trade relationship management.

Mr. He holds a Master of Business Administration degree from Vancouver Island University and a Bachelor’s degree in Chinese literature from Suzhou University.

Jian Shao - Chief Business Development Officer

Since July 2009, Mr. Shao has been the Vice President of Marketing of Nanjing Joymain. As Vice President of Marketing, Mr. Shao is responsible for developing marketing strategies, product promotions and sales incentive programs as well as developing new products for launching in the People’s Republic of China (“PRC”). From June 2008 to July 2009, Mr. Shao was the Marketing Director for Shaklee (China) Co. Ltd. a multi-level marketing company in China, responsible for designing and implementing marketing programs for nutrition products and household and personal care products. From August 2007 to May 2008, Mr. Shao was the CEO of Omnlife China Ltd., a multi-level marketing company in Hefei, Anhui, China. From November 2004 to August 2007, Mr. Shao was the Marketing Director of Pharmanex at NuSkin (China) Daily Health Products Co., Ltd. responsible for health food market programs; he launched Pharmanex products in 2005 and developed product pipelines for the China market. From 1996 to 2004, Mr. Shao was the Associate Product Manager of Pfizer Pharmaceutical Ltd. responsible for Zithromax, an antibiotic medicine, in China. From 1992 to 1995, Mr. Shao was a physician at Huashan Hospital.

Mr. Shao graduated from Shanghai Medical University with a Master’s degree in Clinical Medicine.

Identification of Significant Employees

We have no significant employees, other than Suqun Lin our president, chief executive officer, secretary, and director, and Chengjie He, our chief financial officer and treasurer.

Involvement in Certain Legal Proceedings

To the best of our knowledge, none of our directors or executive officers has, during the past ten years:

1.	been convicted in a criminal proceeding or been subject to a pending criminal proceeding (excluding traffic violations and other minor offences);

2.	any bankruptcy petition filed by or against the business or property of the person, or of any partnership, corporation or business association of which he was a general partner or executive officer, either at the time of the bankruptcy filing or within two years prior to that time;

3.	been subject to any order, judgment, or decree, not subsequently reversed, suspended or vacated, of any court of competent jurisdiction or federal or state authority, permanently or temporarily enjoining, barring, suspending or otherwise limiting, his involvement in any type of business, securities, futures, commodities, investment, banking, savings and loan, or insurance activities, or to be associated with persons engaged in any such activity;

4.	been found by a court of competent jurisdiction in a civil action or by the SEC or the Commodity Futures Trading Commission to have violated a federal or state securities or commodities law, and the judgment has not been reversed, suspended, or vacated;

5.	been the subject of, or a party to, any federal or state judicial or administrative order, judgment, decree, or finding, not subsequently reversed, suspended or vacated (not including any settlement of a civil proceeding among private litigants), relating to an alleged violation of any federal or state securities or commodities law or regulation, any law or regulation respecting financial institutions or insurance companies including, but not limited to, a temporary or permanent injunction, order of disgorgement or restitution, civil money penalty or temporary or permanent cease-and-desist order, or removal or prohibition order, or any law or regulation prohibiting mail or wire fraud or fraud in connection with any business entity; or

6.	been the subject of, or a party to, any sanction or order, not subsequently reversed, suspended or vacated, of any self-regulatory organization (as defined in Section 3(a)(26) of the Exchange Act (15 U.S.C. 78c(a)(26)), any registered entity (as defined in Section 1(a)(29) of the Commodity Exchange Act (7 U.S.C. 1(a)(29)), or any equivalent exchange, association, entity or organization that has disciplinary authority over its members or persons associated with a member.

Code of Ethics

Our board of directors has not adopted a code of ethics due to the fact that we presently only have one director and we are in the development stage of our operations. We anticipate that we will adopt a code of ethics when we increase either the number of our directors and officers or the number of our employees.

Compliance with Section 16(a) of the Securities Exchange Act of 1934

Our common stock is not registered pursuant to Section 12 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”). Accordingly, our officers, directors, and principal stockholders are not subject to the beneficial ownership reporting requirements of Section 16(a) of the Exchange Act.

AUDIT COMMITTEE

We do not have an audit committee financial expert because we believe the cost related to retaining a financial expert at this time is prohibitive. Further, because we have no operations, at the present time, we believe the services of a financial expert are not warranted.

Committees of the Board

All proceedings of our board of directors were conducted by resolutions consented to in writing by all the directors and filed with the minutes of the proceedings of the directors. Such resolutions consented to in writing by the directors entitled to vote on that resolution at a meeting of the directors are, according to the corporate laws of the state of Nevada and the bylaws of our company, as valid and effective as if they had been passed at a meeting of the directors duly called and held.

Our company currently does not have nominating, compensation committees or committees performing similar functions nor does our company have a written nominating, compensation or audit committee charter. Our board of directors does not believe that it is necessary to have such committees because it believes that the functions of such committees can be adequately performed by our directors.

Our company does not have any defined policy or procedure requirements for shareholders to submit recommendations or nominations for directors. The directors believe that, given the early stage of our development, a specific nominating policy would be premature and of little assistance until our business operations develop to a more advanced level. Our company does not currently have any specific or minimum criteria for the election of nominees to the board of directors and we do not have any specific process or procedure for evaluating such nominees. Our directors assess all candidates, whether submitted by management or shareholders, and make recommendations for election or appointment.

A shareholder who wishes to communicate with our board of directors may do so by directing a written request addressed to our president, at the address appearing on the first page of this annual report.

We believe that the member of our board of directors is capable of analyzing and evaluating our consolidated financial statements and understanding internal controls and procedures for financial reporting. We believe that retaining an independent director who would qualify as an "audit committee financial expert" would be overly costly and burdensome and is not warranted in our circumstances given the early stages of our development and the fact that we have not generated any material revenues to date. In addition, we currently do not have nominating, compensation or audit committees or committees performing similar functions nor do we have a written nominating, compensation or audit committee charter. Our board of directors does not believe that it is necessary to have such committees because it believes the functions of such committees can be adequately performed by our board of directors.

ITEM 11.

EXECUTIVE COMPENSATION

Compensation Discussion and Analysis

Compensation Objectives

We operate in a highly competitive and rapidly changing industry. The key objectives of our executive compensation programs are to:

	•	Supervise and review the affairs of the Company as they relate to the compensation and benefits of executive officers and directors of the Company.

	•	Perform any other activities consistent with the Company’s Amended and Restated Memorandum and Articles of Association and governing law, as the Committee or the Board deems necessary or appropriate.

Our Compensation Program

In carrying out its objectives, our Board shall review all components of executive and director compensation for consistency with our compensation philosophy and with the interests of our shareholders.

The compensation program is designed to reward each individual named executive officer for his or her contribution to the advancement of our overall performance and execution of our goals, ideas and objectives. It is designed to reward and encourage exceptional performance at the individual level in the areas of organization, creativity and responsibility while supporting our core values and ambitions. This in turn aligns the interest of our executive officers with the interests of our shareholders, and thus with our interests.

Determining Executive Compensation

Our Board generally reviews and approves the compensation program for executive officers annually after the close of each year. Reviewing the compensation program at such time allows the Board to consider the overall performance of the past year and the financial and operating plans for the upcoming year in determining the compensation program for the upcoming year.

A named executive officer’s base salary is determined by an assessment of his sustained performance against individual job responsibilities, including, where appropriate, the impact of his performance on our business results, current salary in relation to the salary range designated for the job, experience and mastery, and potential for advancement. Although we do not engage in benchmarking, the Board may also consider compensation levels with comparable positions in the industry to evaluate the total compensation decisions that it makes for our officers.

Role of Executive Officers in Determining Executive Compensation

The Board reviews and determines the compensation for our chief officers, which is based on various factors, such as level of responsibility and contributions to our performance

The Board shall review on at least an annual basis the scope of responsibilities of the Board and the Board’s performance of its duties.

Employment Agreements

We have not entered into employment agreements with our senior executive officers. Our Board may adjust base salaries annually to reflect increases in the cost of living, but it has not done so to date. An executive’s base salary may also be increased if the executive’s workload substantially increases as a result of our business expansion. In addition, an executive’s base salary may be correspondingly adjusted if the salaries of all of our other employees are adjusted.

Suqun Lin. We have not entered into an employment agreement with Mr. Lin, our chief executive officer. Mr. Zhuo and the Company have mutually agreed to an annual compensation of USD$10,000. Bonuses will be determined by us in our sole discretion and will be approved by our Board. Mr. Lin is eligible for participation in any standard employee benefit plan of the Company that currently exists or may be adopted by the Company in the future, but not limited to, any retirement plan, and travel holiday policy.

Chenjie He. We have not entered into an employment agreement with Mr. He, our chief financial officer. Mr. He and the Company have mutually agreed to an annual compensation of USD$9,000. Bonuses will be determined by us in our sole discretion and will be approved by our Board. Mr. He is eligible for participation in any standard employee benefit plan of the Company that currently exists or may be adopted by the Company in the future, but not limited to, any retirement plan, and travel holiday policy.

Jian Shao. We have not entered into an employment agreement with Mr. Shao, our chief business development officer. Mr. Shao and the Company have mutually agreed to an annual compensation of USD$9,000. Bonuses will be determined by us in our sole discretion and will be approved by our Board. Mr. Shao is eligible for participation in any standard employee benefit plan of the Company that currently exists or may be adopted by the Company in the future, but not limited to, any retirement plan, and travel holiday policy.

Summary Compensation of Named Executive Officers

The particulars of the compensation paid to the following persons:

	(a)	principal executive officer;

	(b)	each of our two most highly compensated executive officers who were serving as executive officers at the end of the years our ended April 30, 2016 ,2015 and 2014; and

	(c)	up to two additional individuals for whom disclosure would have been provided under (b) but for the fact that the individual was not serving as our executive officer at the end of the years ended April 30, 2016 ,2015 and 2014;

who we will collectively refer to as the named executive officers of our company, are set out in the following summary compensation table, except that no disclosure is provided for any named executive officer, other than our principal executive officers, whose total compensation did not exceed $100,000 for the respective fiscal year:

SUMMARY COMPENSATION TABLE

Name and Principal Position	Year	Salary ($)	Bonus ($)	Stock Awards ($)	Option Awards ($)	Non-Equity Incentive Plan Compensation ($)	Nonqualified Deferred Compensation Earnings ($)	All Other Compensation ($)	Total ($)
Suqun Lin⁽¹⁾	2016	10,000	0	0	0	0	0	0	10,000

President,	2015	10,000	0	0	0	0	0	0	10,000

Chief Executive Officer, Secretary and Director	2014	833	0	0	0	0	0	0	833
Chengjie He⁽²⁾	2016	9,000	0	0	0	0	0	0	9,000

Chief	2015	9,000	0	0	0	0	0	0	9,000
Financial Officer and Treasurer	2014	750	0	0	0	0	0	0	750
Jian Shao⁽²⁾	2016	9,000	0	0	0	0	0	0	9,000

Chief	2015	9,000	0	0	0	0	0	0	9,000

Business Development Officer	2014	750	0	0	0	0	0	0	750

⁽¹⁾	Appointed on March 12, 2013. The Company modified its compensation policy and started to compensate Mr. Lin on April 1, 2014.

⁽²⁾	Appointed on April 1, 2014.

There are no current employment agreements between our company and our three officers. The compensation discussed herein addresses all compensation awarded to, earned by, or paid to our named executive officer. There are no other stock option plans, retirement, pension, or profit sharing plans for the benefit of our officers and directors other than as described herein.

Outstanding Equity Awards at 2016 Fiscal Year End

As of April 30, 2016, there were no outstanding equity awards for our named executive officers.

Long-Term Incentive Plans

There are no arrangements or plans in which we provide pension, retirement or similar benefits for directors or executive officers. Although we do not have a formal broad based bonus plan, we may award bonuses on case-by-case basis depending on the terms of specific of employment agreements and other arrangements based on our financial performance as well as the executive’s performance which are determined by the Board in its sole discretion. We do not have any material bonus or profit sharing plans pursuant to which cash or non-cash compensation is or may be paid to our directors or executive officers, except that stock options may be granted at the discretion of our Compensation Committee.

As of the date of this 10K, we have no compensatory plan or arrangement with respect to any officer that results or will result in the payment of compensation in any form from the resignation, retirement or any other termination of employment of such officer’s employment with our company, from a change in control of our company or a change in such officer’s responsibilities following a change in control where the value of such compensation exceeds $60,000 per executive officer.

Director Compensation

We did not pay compensation to any non-employee directors during the fiscal year 2016.

We do not pay our directors in connection with attending individual Board meetings, but we reimburse our directors for expenses incurred in connection with such meetings.

Pension, Retirement or Similar Benefit Plans

There are no arrangements or plans in which we provide pension, retirement or similar benefits for directors or executive officers. We have no material bonus or profit sharing plans pursuant to which cash or non-cash compensation is or may be paid to our directors or executive officers, except that stock options may be granted at the discretion of the board of directors or a committee thereof.

Indebtedness of Directors, Senior Officers, Executive Officers and Other Management

None of our directors or executive officers or any associate or affiliate of our company during the last two fiscal years, is or has been indebted to our company by way of guarantee, support agreement, letter of credit or other similar agreement or understanding currently outstanding.

ITEM 12.

SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT AND RELATED STOCKHOLDER MATTERS

The following table provides certain information regarding the ownership of our common stock, as of July 28, 2016 by:

	-	each of our executive officers;
	-	each director;
	-	each person known to us to own more than 5% of our outstanding common stock; and
	-	all of our executive officers and directors and as a group.

	Name and Address of	Amount and Nature of
Title	Beneficial Owner	Beneficial Ownership⁽¹⁾	Percentage
of Class

Common Stock	Suqun Lin⁽²⁾	Nil	0%
	No. 30 N. Zhongshan Road, Floor 40,	shares of common stock
	Guluo District, Nanjing , Jiangsu
	Province, P.R.C. 210008

Common Stock	Xijian Zhou	677,000,000⁽³⁾	60.4%
	No. 30 N. Zhongshan Road, Floor 38,	shares of common stock (direct)

Common Stock	Chengjie He
	No. 30 N. Zhongshan Road, Floor 38,	Nil	0%
	Guluo District, Nanjing	shares of common stock
	Jiangsu Province, P.R.C. 210008

⁽¹⁾

The number and percentage of shares beneficially owned is determined under rules of the SEC and the information is not necessarily indicative of beneficial ownership for any other purpose. Under such rules, beneficial ownership includes any shares as to which the individual has sole or shared voting power or investment power and also any shares which the individual has the right to acquire within 60 days through the exercise of any stock option or other right. The persons named in the table have sole voting and investment power with respect to all shares of common stock shown as beneficially owned by them, subject to community property laws where applicable and the information contained in the footnotes to this table.

⁽²⁾	Suqun Lin is our president, secretary, Chief Executive Officer and director.

⁽³⁾	The percent of class is based on 1,120,343,373 shares of common stock issued and outstanding as of April 30, 2016.

CHANGES IN CONTROL

On March 12, 2013, pursuant to the terms of a share exchange agreement, Mr. Xijian Zhou acquired an aggregate of 750,000,000 shares of our common stock, representing 82.92% of our issued and outstanding shares as of March 12, 2013. Effective March 12, 2013, (a) Mr. Liang Wei Wang resigned as president, secretary, treasurer, and director of our company; (b) Mr. Suqun Lin, was appointed as our sole director, president, secretary and treasurer. Our company did not receive any proceeds from the transaction. In accordance with the terms of the agreement our company at the closing of the agreement had no assets and liabilities.

ITEM 13.

CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS; AND DIRECTOR INDEPENDENCE

We have not entered into any transaction since the beginning of the last fiscal year with any director, executive officer, director nominee, 5% or more shareholder, nor have we entered into transaction with any member of the immediate families of the foregoing person (including spouse, parents, children, siblings, and in-laws) or is any such transaction proposed, except as follows:

For the year ended April 30, 2016, the Company’s majority shareholder did not advanced the Company for general expenses and the Company made repayments of shareholder’s advances in the amount of $3,294. For the year ended April 30, 2015, the Company’s majority shareholder advanced the Company $8,290 for general expenses and professional fees and the Company repaid the major shareholder $44,676. The advances are non-interest bearing, due upon demand and unsecured. For the year ended April 30, 2014, the Company’s majority shareholder advanced the Company $60,782 for general expenses and professional fees and the Company repaid the major shareholder $48,040. The advances are non-interest bearing, due upon demand and unsecured. At April 30, 2016 and 2015, the Company’s due to related parties amounted to $235 and $3,529, respectively.

Director Independence

Presently, we are not currently listed on a securities exchange that requires us to comply with director independence requirements. In determining whether our directors are independent, however, we intend to comply with the rules of NASDAQ. The board of directors will also consult with counsel to ensure that the boards of director’s determinations are consistent with those rules and all relevant securities and other laws and regulations regarding the independence of directors, including those adopted under the Sarbanes-Oxley Act of 2002 with respect to the independence of audit committee members. Nasdaq Listing Rule 5605(a)(2)defines an “independent director” generally as a person other than an Executive Officer or employee of the Company or any other individual having a relationship which, in the opinion of the Company's board of directors, would interfere with the exercise of independent judgment in carrying out the responsibilities of a director. We currently act with only one director and have determined that he is not an “independent director” as defined in NASDAQ Marketplace Rule 4200(a)(15).

ITEM 14. PRINCIPAL ACCOUNTING FEES AND SERVICES

The following table sets forth the fees billed by our principal independent accountants, RBSM LLP, for of our last three fiscal years for the categories of services indicated.

	Years Ended
	April 30, 2016	April 30, 2015	April 30, 2014
Audit Fees	$ 37,000	$ 18,000	$ 8,000
Audit Related Fees	4,000	8,000	-
Tax Fees	6,000	5,000	-
All Other Fees	-	-	-
Total	$ 47,000	$ 31,000	$ 8,000

Audit fees. Consists of fees billed for the audit of our annual financial statements, review of our Form 10-K, review of our interim financial statements included in our Form 10-Q and services that are normally provided by the accountant in connection with year-end statutory and regulatory filings or engagements.

Audit-related fees. Consists of fees billed for assurance and related services that are reasonably related to the performance of the audit or review of our financial statements and are not reported under “Audit Fees”, review of our Form S-1 filings and services that are normally provided by the accountant in connection with non-year-end statutory and regulatory filings or engagements.

Tax fees. Consists of professional services rendered by a company aligned with our principal accountant for tax compliance, tax advice and tax planning.

Other fees. The services provided by our accountants within this category consisted of advice and other services relating to SEC matters, registration statement review, accounting issues and client conferences.

Our board of directors pre-approves all services provided by our independent auditors. All of the above services and fees were reviewed and approved by the board of directors either before or after the respective services were rendered.

Our board of directors has considered the nature and amount of fees billed by our independent auditors and believes that the provision of services for activities unrelated to the audit is compatible with maintaining our independent auditors’ independence.

PART IV

ITEM 15. EXHIBITS, FINANCIAL STATEMENT SCHEDULES

(a)	Financial Statements

	(1)	Financial statements for our company are listed in the index under Item 8 of this document;

	(2)	All financial statement schedules are omitted because they are not applicable, not material or the required information is shown in the financial statements or notes thereto.

(b)

Exhibits

Exhibit	Description
Number
(3)	(i) Articles of Incorporation; (ii) Bylaws
3.1	Articles of Incorporation (incorporated by reference to our Registration Statement on Form S-1 filed on May 31, 2011)
3.2	Bylaws (incorporated by reference to our Registration Statement on Form S-1 filed on May 31, 2011)
3.3	Certificate of Amendment (incorporated by reference to our Current Report on Form 8-K filed on April 11, 2013)
(10)	Material Contracts
10.1	Consultant Agreement between the Company and LP Funding, LLC dated May 10, 2014 (incorporated by reference to our Current Report on Form 10-Q filed on September 12, 2014)
(31)	Rule 13a-14(a) / 15d-14(a) Certifications
31.1*	Certification pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 of the Principal Executive Officer
31.2*	Certification pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 of the Principal Financial Officer and Principal Accounting Officer
(32)	Section 1350 Certifications
32.1*	Certification pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 of the Principal Executive Officer, Principal Financial Officer and Principal Accounting Officer
101*	Interactive Data Files
101.	INS XBRL Instance Document
101.	SCH XBRL Taxonomy Extension Schema Document
101.	CAL XBRL Taxonomy Extension Calculation Linkbase Document
101.	DEF XBRL Taxonomy Extension Definition Linkbase Document
101.	LAB XBRL Taxonomy Extension Label Linkbase Document
101.	PRE XBRL Taxonomy Extension Presentation Linkbase Document

* Filed herewith.

SIGNATURES

In accordance with Section 13 or 15(d) of the Exchange Act, the registrant caused this report to be signed on its behalf by the undersigned, thereunto duly authorized

	Joymain International Development Group Inc.

Dated: August 22, 2016	By: /s/ Suqun Lin
	Suqun Lin
	President, Chief Executive Officer,
	Secretary and Director

Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.Each person whose signature appears below hereby authorizes Suqun Lin as his true and lawful attorney-in-fact and agent, with full power of substitution and resubstitution for him or her and in his or her name, place and stead, in any and all capacities to sign any and all amendments to this report, and to file the same, with all exhibits thereto and other documents in connection therewith, with the Securities and Exchange Commission.

Signature	Title	Date

/s/ Suqun Lin	President, Chief Executive Officer	August 22, 2016
Suqun Lin	Secretary and Director

/s/ Chengjie He	Chief Financial Officer and	August 22, 2016
Chengjie He	Treasurer
	( Principal Accounting Officer)

/s/Jian Shao
Jian Shao	Chief Business Development Officer	August 22, 2016

JOYMAIN INTERNATIONAL DEVELOPMENT GROUP INC. 10-K